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Abstract
Justin D. Horgan
ENDEAVORS TOWARD NOVEL SYNTHETIC ROADMAPS IN THE SYNTHESIS
OF PERTINENT PHARMACOLOGICAL MOLECULAR SCAFFOLD MOIETIES
2019-2020
Gustavo Moura-Letts Ph.D.
Master of Science in Pharmaceutical Sciences
One of the main goals in the GML lab group is the development of novel,
economical, and environmentally friendly organic methods for the synthesis of
pharmacologically relevant molecular moieties. The most salient pieces of data to the
GML lab group members, reading dependable organic journals, are finding organic
moieties that are largely unexplored, finding organic moieties which various research
groups are having difficulty synthesizing, and finding complex organic procedures to key
organic structures that can be easily reduced, or reconstructed, into novel methods that
are more economical and environmentally friendly. By looking at these unexplored
molecules, as well as hard to reach organic moieties, the GML lab group employs various
organic methods to break down the target moiety at hand in order to recreate these
compounds using superior novel methodologies. In my time working within the GML lab
group , I successfully introduced a novel synthesis route for the Lewis acid catalyzed
synthesis of hexahydrobenzofuranones, a selective synthesis of pyrrolidines, pyrrolines,
and azepines from haloaziridines, and a photoisomerization reaction of vinyl oxaziridines
from vinyl nitrones. It is the hope of the GML lab to use these synthetic strategies, and
the respective synthesis routes developed from them, to improve on existing synthetic
organic chemistry through reactions which rely on mild conditions to afford crucial
organic moieties.
v
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Chapter 1
Novel Synthesis of Hexahydrofuran-4(2H)-Ones
Hexahydrofuran-4(2H)-ones, one of the current GML lab group target moieties,
are a part of a large family of organic compounds known as fused heterocycles;
compounds containing two, mainly carbon based, organic ring structures which are
bridged together at two carbons. Heterocyclic compounds are commonly used as
privileged pharmacophores in the creation of new pharmaceutical agents. Fused
heterocycles play this fundamental roll in drugs design as they are often good sources of
scaffolding molecules in both blockbuster drugs and natural products in part due to do the
structural rigidity, as well as other key features, that fused heterocycles can bring to an
experimental pharmacophore. As mentioned before, the heterocyclic compound of
current interest to the GML lab group is hexahydrofuran-4(2H)-ones specifically through
the novel synthesis of fused, cyclic ethers via cycloaddition reactions between aldehydes
and substituted cyclopropanes. Through this novel method, the GML lab group has been
able to successfully access hexahydrofuran-4(2H)-ones, with a wide variety of
functionalization, thus helping to meet the continuous demand for the development of
more efficient and systematic methods to reach these key structures. Before going
through previous synthetic routes to afford hexhydrofuran-4(2H)-ones, it is vastly
important to cover key chemical features that these hexahydrofuran-4(2H)-one products
embody for chemical context.
The chemical structure of hexahydrofuran-4(2H)-ones, as shown in Figure 1, is
characterized by a bicyclic moiety containing a six membered cyclic carbon ring structure
1

with one carbonyl functional group attached to the cyclohexane ring. If the six membered
cyclic hydrocarbon ring, as previously mentioned, was the complete molecular structure,
it would have the IUPAC name cyclohexanone. The cyclohexanone ring shares two
adjacent carbons with a five membered cyclic organic ring made up of one oxygen atom
and four carbon atoms, known by the systematic name tetrahydrofuran. The
tetrahydrofuran ring, in the hexahydrobenzofuran-4(2H)-one final product, is further
substituted by two electron withdrawing groups, both sharing a single carbon on the
tetrahydrofuran ring. Various mono- and di-ester hydrocarbon chains have been
implemented into each of the hexahydrobenzofuran-4(2H)-one moieties synthesized,
through the second step of the novel synthesis of hexahydrobenzofuran-4(2H)-ones, in
order to test which mono- or di-ester complex would afford the best yielding
hexahydrobenzofuran-4(2H)-one products using the GML synthesis route. Each of the
ester hydrocarbon complexes tested are attached to the carbon atom on the
tetrahydrofuran ring by the mono- or di-ester carbon that is in between each of the
carbonyl groups on the di-ester complex or adjacent to the single carbonyl functional
group of the of the mono-ester hydrocarbon chain. This specific substituent addition
creates an inverse stereochemical configuration of each half of the mono- or di-ester
hydrocarbon complex. Adjacent to the electron withdrawing ester hydrocarbon
substituents, labeled as “EWG” in Figure 1, is a “R1” labeled substituent which represents
a variety of heterocyclic functional groups, derived from heterocyclic aldehydes
substituted in “R1” position, in the novel synthesis of hexahydrobenzofuran-4(2H)-one.
Using heterocyclic aldehyde substituents as the “R1” substituent gives the
hexahydrobenzofuran-4(2H)-one moiety further rigidity and stability as well as granting
2

the final product complex the ability to be further synthesized into more complex fused
heterocyclic compounds.

Figure 1
Hexahydrobenzofuran-4(2H)-One Target Moiety

Now that some basic chemical characterization of hexhydrobenzofuran-4(2H)ones have been covered, it is important to have an overview of organic synthesis routes
from the past towards hexahydrofuran-4(2H)-one-like products but also to envelop the
scientific findings that laid the foundation for the optimized, novel synthesis route
designed for the synthesis of hexahydrofuran-4(2H)-ones.
1.1 Review of Hexahydrobenzofuranones
In order to successfully add to the paradigm of knowledge on the synthesis of
hexahydrobenzofuranone moieties, organic chemists must first study the synthesis routes
towards hexahydrobenzofuranones which have already been exploited. These studies give
key insights into the target moiety as well as potential challenges that one might run into
3

when attempting to synthesize hexahydrobenzofuranones. One of the first instances of the
synthesis of hexahydrobenzofuranones comes from the Pharmaceutical Institute of the
University of Kiel in 1954 by German chemists Karl W. Rosenmund, Horst Herzberg,
and Hartwig Schutt. Rosenmund and his colleagues used hexahydrobenzofuranones as
synthetic building blocks for the creation of a class of antiparasitic drugs known as
anthelmintics. The synthesis for these hexahydrobenzofuranones is depicted below in
Figure two, showing the eventual stepwise formation of the hexahydrobenzofuranone
product 8.

Figure 2
Hexahydrobenzofuranone Building Blocks for Anthelmintic Synthesis

The synthesis route, depicted above in Figure 2, begins with combining molecule
3 with three equivalences of acetyl chloride for four hours under high pressure and heat.
The work-up of this step then begins with cooling the reaction in an ice and salt bath
while slowly adding 100 milliliters of ether to the crude reaction solution through rubber
tubing to keep the reaction pressure stable. The crude reaction was then dried, to remove
4

organic solvent present, and then resuspended in twenty-five milliliters of acetic acid
followed by dilution of the reaction with seventy-five milliliters of petroleum ether.
Crystals were then formed and isolated in the reaction vessel to isolate compound 5. One
gram of five molar percent palladium/barium sulfate catalyst, also known as the
Rosenmund catalyst, 13.5 milligrams of hydrated iron three chloride in 100 milliliters of
ethanol, and two grams of compound 5 were resuspended in 30 milliliters of ethanol until
one mole of hydrogen had dissipated from the reaction. The Rosenmund catalyst was
removed via centrifugation and the solution was rotatory evaporated to yield the semipure, white crystal of hexahydrobenzofuranone 8. (5) The purification process was
completed via an ether-carbonate precipitation to successfully yield the pure crystalized
compound 8. Rosenmund and his colleagues successfully employed
hexahydrobenzofuranones to synthesize enol-lactone complexes of hydrogenated cyclic
1,3-diketones containing useful anthelmintic properties. This first publication, illustrated
above, shows that from the very genesis of the synthesis of hexahydrobenzofuranones,
chemists intended to exploit this powerful moiety to create complex structures with
pharmacological properties to be used in the synthesis of new pharmaceutical agents.
Daniewski and Kowalcyk-Przewloka have shown that hexahydrobenzofuranones
can be used precursors in the total synthesis of cyclic steroids. Figure 3 shows a step in
the synthesis route towards cyclic steroids with molecule 1 being converted into molecule
2 containing the hexahydrobenzofuranone moiety under relatively benign conditions.
This process was completed by adding the inorganic catalyst tin (IV) chloride in
methylene chloride to the starting material at room temperature. Tin (IV) chloride is
commonly employed by organic chemists as a Lewis acid catalyst in Friedel-craft
5

reactions for alkylation and cyclization transformations as well as used with fuming nitric
acid for selective nitration of aromatic organic structures. (7) The reaction was left
overnight to stir which was then followed by the addition of 20 mL of water, the
extraction of methylene chloride, drying of the reaction using sodium sulfate, and
purification completed via flash chromatography. This reaction led to over eighty percent
conversion of the pure diastereo-isomer of molecule 2 in figure 3 according to analyzed
NMR spectrum data. (6)

Figure 3
Hexahydrobenzofuranone Precursor in Total Synthesis of Aromatic Steroids

It is important to note that the functionalized tetrahydrofuran molecule, which is
contained within the hexahydrobenzofuranone moiety, is a sought-after structure to
synthesis in an economic fashion as it is found in plenty of natural products as well as
active medicinal agents. Therefore, when exploring the different synthetic methods to
establish hexahydrobenzofuranones, it is not unlikely to come across methodologies that
are initially intended for the synthesis functionalized, stereo-controlled tetrahydrofurans.
Functionalized tetrahydrofurans are commonly established by intramolecular
6

etherification reactions from acyclic fragments as well as from C-C bond formation. (10)
A versatile C-C bond formation methodology used to create 3-acyltetrahydrofurans by
stitching the carbonyl carbon of aldehydes and ketones in between the alkene and alcohol
termini of an allylic diol. (11) While this process has high stereoselectivity as well as
being a cornerstone reaction for the synthesis of numerous oxacyclic natural products, the
reaction holds the limitation of an inability to synthesize tetrahydrofurans with two
hydrogen substituents on the C5 carbon of the tetrahydrofuran produced. In the following
procedure depicted in figure 4, Gasparski and her colleagues modify the synthesis of 3acyltetrahydrofurans previously mentioned, to solve the reaction’s shortcoming, through
the development of formaldehyde oxonium ion intermediates which allow for 5unsubstituted tetrahydrofurans to be prepared. In order to form the oxonium ions, the
homoallylic alcohol of the allylic diol precursors were protected with methoxymethyl,
OMOM, and to prevent the formation of 1,3-dioxolane the allylic alcohol was protected
via a tert-butyldimethylsilyl, TBS, functional group. As seen in Figure 4, the allylic diol
precursor on the left is exposed to a solution of boron trichloride in the organic solvent
dichloromethane, DCM, at -78 degrees Celsius for one to two hours. The mechanistic
studies, reported by Gasparski’s group, showed a Prins cyclization-pinacol rearrangement
pathway for the synthesis of 5-unsubstituted tetrahydrofurans. The Lewis acid catalyzed
organic synthesis shown in this example successfully proves the synthesis of
hexahydrobenzofuranones to be carried out under mild, stereo-selective conditions. (9)

7

Figure 4
Synthesis of Cis-Hexahydrobenzofuranones From Derived Trans-1-Alkenylcyclopentane1,2-Diols

Another interesting method employed Yu et al was to utilize hydrogenation
reactions to create multi-substituted cyclohexanes with discrete stereogenic centers. In
Yu’s lab group esterified 1,3-cyclohexanediones were employed to build polysubstituted
cyclohexane skeletons. These esterified 1,3-cyclohexanediones underwent
desymmetrization/transesterification cascade reactions when exposed to a chiral
ruthenium catalyst and a formic acid/triethylamine solution in ethyl acetate at 25 degrees
Celsius for 24 hours in order to afford hexahydrobenzofuranones. (16) Yu et al’s method
allows for the continuous access to chiral multi-substituted cyclohexane skeletons to be
then transformed, in future organic projects, for natural product synthesis.
As seen in some of strategies mentioned before, the creation of
hexahydrobenzofuranones is commonly accomplished under the addition of specific
Lewis acids, but the mechanistic strategies to achieve these key moieties differs in each
research group. Stereo-selective synthesis of hexahydrobenzofuranones was pursued by
Herrinton et al through ring enlarging furan annulations. (12) In this synthesis, a variety
of substituted cis-fused hexahydrobenzofuranones, octahydrobenzofuranones, and
8

cycloheptanetetrahydrofuranones were established through acid-promoted rearrangement
of acetals derived from 1-alkenyl-2-hydroxycyclopentanols as well as 1-alkenyl-2hydrocyclopentanols. Several Lewis acids were successfully utilized by Herrinton and his
colleagues towards this synthesis route including boron trifluoro etherate, tin
tetrachloride, ethylaluminum dichloride, and magnesium bromide. It was later discovered
that the Lewis acid dimethylaluminum chloride was ineffective for these procedures.
While this strategy for creating fused bicyclic moieties was tested with organic rings of
only three sizes, Herrinton and his group believe that this can be applied to even larger
rings as well as applying this route to the synthesis of pharmaceutically relevant complex
cyclic ethers. (12)
Radical reagents are also used to catalyze the synthesis of hexahydrobenzofuranones,
such as tri-n-butyltin hydride, which can be employed to induce reductive cleavage,
radical dehalogenation, and radical cyclization reaction. (15) This is exemplified by
Macdonald and Burnell as they developed a synthetic pathway towards the natural
product Pestaloficiol A, using the hexahydrobenzofuranone moiety as a molecular
foundation, which was found to have anti-HIV activity. (13) In this section, the synthesis
towards the hexahydrobenzofuranone moiety will only be described as the rest of the
synthesis pathway towards Pestaloficiol A will be explored in the
hexahydrobenzofuranone pharmaceutical application section. As shown in Figure 5,
Macdonald and Burnell prepared the hexahydrobenzofuranone precursor for Pestaloficiol
A by first reaction propargyl alcohol with cyclohexanone in the presence of NBS and
sulfuric acid to give the bromo ether starting material in Figure 5. This was then followed

9

by inducing radical cyclization of the bromo ether starting material with tri-n-butyltin
hydride to give the hexahydrobenzofuranone complex in 88% -92% yield. (14)

Figure 5
Hexahydrobenzofuranone Moiety Within Pestaloficiol A Synthesis

Recent organic studies completed by Xiao’s group found that phosphine catalysts
can be applied towards dearomative [4+2] cycloadditions in order to create
hexahydrobenzofuranone containing moieties. It was found from Xiao’s group, after
exploring various phosphine catalysts used by other organic research groups, that
phosphine catalysts which were substituted by fused bicyclic as well as 3,5dimethylphenyl substituents showed greater success in producing
hexahydrobenzofuranone moieties. In this synthesis strategy, 1-(benzofuran-3-yl) prop-2en-1-one was reacted with a highly electrophilic 3-olefinic 7-azaoxindole catalyzed by
the cyclic phosphine catalyst at 5 degrees Celsius for twelve hours synthesized
hexahydrobenzofuranones containing moieties in 88% stereoselective yields. (17) This
methodology could prove to be quite economically useful in industry as it creates
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principle hexahydrobenzofuranone moieties in a one pot reaction under relatively mild
conditions.
Photo-organocatalytic reactions have been a staple strategy employed by organic
chemists as they provide simple organic procedures under lenient conditions to create
otherwise hard to reach organic scaffolds. The next two synthetic examples will cover
two groups that have employed photocatalytic reactions to afford
hexahydrobenzofuranone moieties. The first synthetic schematic, applied by Perego’s
group, explored single-electron transfer (SET) activation of allenes through a light-driven
enantioselective organocatalytic process. (18) To begin this process, chiral iminium ions
were photocatalytically transformed into their excited state to activate allenes through the
SET oxidation. The activated allene cation radicals then participated in stereo-controlled
cascade reactions to deliver chiral bicyclic hexahydrobenzofuranone scaffold with good
enantioselectivity and diasteroeselectivity. Lewis acids were later employed for Perego’s
synthetic strategy in order to assist in the formation of the activated chiral iminium ion
providing higher yields and full diastereoselective control of the reaction. (19)
While photochemical reactions have proven to be useful tools in the synthesis of
complex organic scaffolds such as hexahydrobenzofuranones, the efficiency of these
photo-induced reactions are restrained, especially when using batch reactors, by the
amount of light that is able to penetrate through the reaction media. (20) To combat this
drawback to photochemical, El Achi’s group employs the use of a continuous flow
system reactor as microfluidic systems have small optical path lengths to ensure more
efficient sample irradiation as well as being a simple and cost-effective reaction system.
(21) El Achi’s group uses the continuous flow system to provide kinetic and optimization
11

studies on their intramolecular [2+2] photocycloaddition of 3-alkenyloxy-2cycloalkenones derivates under UV-A irradiation. El Achi’s group successfully
demonstrated a photo-catalytically sensitized intramolecular [2+2] cycloaddition using
the photosensitizer DMBP in a commercial photomicroreactor irradiated by High Power
UV-A LEDs forming hexahydrobenzofuranone containing structures in a 2-hour reaction
time. (22)
Photo-organocatalyzed cycloadditions reactions are known to undergo freeradical mechanisms but inducing radical cyclization reactions through other catalytic
systems can also be a versatile method applied to synthesize polycyclic fused
heterocycles which contain similar organic moieties to the hexahydrobenzofuranone
scaffolds. The use of radicals allows organic chemists to include high functionality
tolerance, within mild reaction conditions, which leads to high levels of regio- and
stereoselectivity within the achieved organic products. (23) Namely, reductive radical
cyclization has been a prominent organic strategy to afford 6-5 fused bicyclic structures
which closely resemble hexahydrobenzofuranones.
In these reductive methodologies, the initial radical is generated via a one-electron
transfer agent towards the precursor of the reaction. (24) This method is quite suitable for
cyclization reactions as the nucleophilic radicals enabled by this method are not easily
reduced. A good example of this reductive radical reaction outlined previously is
Molander and Harring’s work in which samarium (II) iodide in the organic solvent
tetrahydrofuran is mixed with hexamethylphosphoramide at 25 degrees Celsius to
transform 1-(allyloxy)-2-iodobenzene into a dihydrobenzofuran complex. In this
reductive method, aryl iodides and/or bromides are used as precursors which generate an
12

aryl radical through single-electron transfer followed by the loss of iodide. The cyclic
radical is then reduced to an organometallic intermediate, often involving the metal
complex mentioned previously, samarium (II) iodide, for its solubility in organic
solvents, high reducing power, and excellent chemo-selectivity. (25) This organometallic
intermediate is then able to react with electrophilic molecules completing this radical
cyclization reaction and affording hexahydrobenzofuranone structures.
Another radical organic strategy involving the use of samarium (II) iodide is in
sequential radical cyclization, specifically where fragmentation of the precursor precedes
the cyclization. Sequential reactions are useful in radical reactions as most radical
reactions such as fragmentation, cyclization, or addition product a new radical that can
serve as a precursor for the second radical reaction to occur. (26) As seen by the reaction
schematic below in figure 6, the initial radical is formed by fragmentation of the
cyclopropyl ketone in order to then produce chiral radicals through a secondary radical
reaction. This reaction is possible as cyclopropanation methods can produce precursors
for radical reactions which are optically pure. (27) This same method can also be
employed for an oxygen centered radical if epoxide is used in place of the cyclopropane
ring, as shown in Figure 6, to design hexahydrobenzofuranone molecular skeletons.

13

Figure 6
Hexahydrobenzofuranone Synthesis Through Sequential Radical Cyclization

While metal hydride-based reagents are commonplace in initiating radical
cyclization reactions, chain transfer agents can also be utilized to conduct fragmentation
reactions of cyclic radicals which contain hexahydrobenzofuranone-like moieties.(23)
One example of this, completed by Smith et al, generated a sulfone radical through
reversible addition to a double bond to initiate radical isomerization reaction. During this
reaction, an allylic sulfone was cyclized with benzoyl peroxide and carbon tetrachloride
in reflux. The main advantage for this synthetic pathway lies in the fact that there is no
competition with side reactions occurring in the direct reduction of the radical acceptor
due to the lack of the metal hydride in the reaction. With this lack of reaction
competition, slow cyclization reactions can be conducted with less reactive precursors as
well as the ability to maintain double bonds within the transformed structure. (28) As
seen in the last few synthetic examples, radical cyclization reactions allow for diverse
strategies to afford hexahydrobenzofuranones, or structures that are easily transformed
into them. As seen through this selection of works to produce hexahydrobenzofuranones,
there are many organic strategies that have employed a variety of catalytic systems to
14

create hexahydrobenzofuranones, but there are still many unexplored organic strategies
which can be exploited for innovative and economical reactions that create and use these
crucial organic structures.
1.2 Pharmaceutical Relevance
One of the major focuses of the Moura-letts lab group is the development of novel
organic methods to synthesis small organic molecules that are likely to have biological
activity. The creation of new biologically active organic compounds act as the foundation
for the entire process of creating new pharmaceuticals. When a scope of organic
compounds is first synthesized, which have a high likelihood of being biologically active,
it can then be run through a series of biochemical experiments such as biological-activity
matrices, high-throughput phenotypic screens, various protein-binding assays to confirm
their activity. (3) Once the organic molecules within the new organic scope are vetted
through screening for biologically active, they have the chance of being manipulated as
scaffolding molecules, building blocks for complex pharmacophores, or even used as a
complete pharmacophores, in the pharmaceutical industry and academia, for the
development of pharmaceutical agents of the future. Pharmacophores can be
characterized as an ensemble of organic moieties and/or functional groups which contain
crucial steric and electronic features. These key features are required to ensure optimal
organic supramolecular interactions with a specific biological target as well as
trigger/block the target’s effects. (2) A large family of organic compounds known as
fused heterocycles, two adjacent ring structures that share two carbons, are commonly
used as privileged pharmacophores. (1) The following section will discuss a range of
synthetic methods for the application of hexahydrobenzofuranones, used by organic
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chemists in academia and in industry, to develop new pharmaceutical agents as well as
the medicinal properties that these pharmaceutical agents hold.

Figure 7
Steroid Synthesis From Hexahydrobenzofuranone Intermediate

As mentioned previously, hexahydrobenzofuranones are crucial target moieties as
they can lead to the novel development of featured organic structures as well as serve as
the backbone for new biologically active molecular scaffolds. Daniewski’s work on the
synthesis route towards hexahydrobenzofuranones, within the total synthesis of aromatic
steroids, is a great example of just one of the synthetic applications that
hexahydrobenzofuranones can bring. In Figure 7, shown above, it can be seen how once
synthesized, the hexahydrobenzofuranone containing structure on the left can undergoes
a simple hydrogenation reaction followed by acetic acid and perchloric acid catalyzed
cyclization to afford the 6,6,6,5 steroidal backbone. (6) At this point the steroidal
backbone can be easily converted in any steroid for use as pharmacological agents or for
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further manipulation to create even more complex, biologically active polycyclic
structures.
Coming up with novel synthetic strategies for the total synthesis of natural
products is a crucial endeavor which is undertaken by many organic chemists. The
following examples include natural product synthesis where hexahydrobenzofuranones
are used as synthetic precursors to afford natural products. One of the most profound
features of hexahydrobenzofuranones are their ability to be transformed into featured
natural products. As mentioned in Figure 5, Macdonald and Burnell aimed to use the
hexahydrobenzofuranone skeleton in order to complete the natural product synthesis of
Pestaloficiol A. Pestaloficiol A is a colorless oil isolated from the plant endophyte
Pestalotiopsis fici which has shown to be a rich source of bioactive secondary
metabolites with diverse structural features. (29) One of the most prominent bioactive
metabolites that have been isolated from this plant source thus far is chloropupukeananin,
the first chlorinated pupukeanane derivate which possesses anti-HIV-1 properties from its
highly functionalized tricyclo-decane skeleton. (30) As seen in Figure 8 above, the
hexahydrobenzofuranone skeleton, formed by through a radical cyclization reaction, was
acylated by a R, β-unsaturated acid chloride to afford the molecule on the top right of
Figure 8. This molecule was then headed in 1:1 THF/water solution with 0.1
equivalences of TsOH to induce cyclization to afford polycyclic structure, in 80 percent
yields, which can be then converted through further organic transformations into
Pestaloficiol A.
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Figure 8
Pestaloficiol A Natural Product Synthesis

Rogers and Keay have also utilized and studied the effects of
hexahydrobenzofuranones as a key intermediate for the synthesis of the natural product
1,4-epoxycadinane. 1,4-epoxycadinane is an important organic target as it is isolated
from the brown algae Dilophus fasciola and known to have a large variety of biological
activity, such as antimicrobial and adhesive properties, which are applicable in
pharmacology. (31) The hexahydrobenzofuranone moiety was synthesized via an
intramolecular Diels-Alder reaction of the Furan diene (IMDAF) connecting the furan
diene to the dienophile which was separated by a four-carbon chain. The furan diene was
dissolved in dichloromethane containing florisil and stirred under argon for an allotted
amount of time. (32) Once the hexahydrobenzofuranone containing structure was
isolated, depicted in Figure 9, it was applied to the synthesis of 1,4-epoxycadinane.
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Another application of the hexahydrobenzofuranone skeleton was deployed by
Endoma-Arias and Dela Paz in developing derivatives of 10-keto opiates as well as 10hydroxy-morphinans for use as selective, opioid receptor κ analgesics. (33) Of the three
types of opioid receptors, µ, δ, and κ, in the body the κ-opioid receptor has piqued the
interest of researchers recently as, when activated, the κ receptor produces analgesia with
minimal physical dependence. (34) This means that drugs that come about as highly
selective κ-opioid receptor agonists would prove to be useful analgesics as well as free
from abusive potential. (35) In order to synthesize key structures such as 10-keto opiates,
10-hydroxy-morphinans, and related morphine alkaloids, a hexahydrobenzofuranone
containing lactam intermediate was planned to reach these molecular skeletons more
easily.

Figure 9
Natural Product Synthesis of 1,4-Epoxycadinane

In another application of hexahydrobenzofuranones for useful synthetic
transformations, Yu’s group have synthesized a hexahydrobenzofuranone-containing,
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fused 6,3,5-tricyclic intermediate in order to afford the antibiotic mycorrhizin A.
Mycorrhizin A was first isolated and characterized by Wickberg and Trofast in 1977
from a sterile mycelium of an endomycorrhizinal fungus. (36) This target compound
possesses a variety of biological activities which could be employed in antifungal and
antibiotic pharmaceutical agents. (37) Previous efforts towards the synthesis of the basic
angularly fused 6,3,5-tricyclic skeleton has been limited to date as only two elegant
strategies have been reported for such tricyclic ring systems. The first synthetic approach
was revealed by Smith’s group, in which an intramolecular SN2 reaction was utilized for
construction of the cyclopropane ring of the tricyclic system, and the second was
introduced Brown and co-workers reporting the synthesis of these structures through
cycloaddition of diazomethane and an olefin followed by extrusion, through ultraviolet
irradiation, of the nitrogen from the reaction, leading to the formation of the
cyclopropane ring of the tricyclic system. (38) (39) Yu and colleagues provided a new
method to afford this 6,3,5-tricyclic structure through intramolecular cyclization of a πnucleophile with an epoxide-containing adduct. Yu and his co-worker’s reaction proceed
via an initial attack of the double bond on the epoxide ring leading to a
cyclopropylcarbinyl cation intermediate. The intermediate formed, however, is to be
considered as a nonclassical or delocalized cation that is unstable without the correct
substituents at the appropriate positions. If these substituents were not in place, ringopening and rearrangement procedures would be induced on the intermediate. Among the
Lewis acids employed by Yu to catalyze this reaction, BF3OET2 and CF3SO3H, in
acetonitrile at room temperature for 3-5 minutes, were found to promote the 3-exo
cyclization of the allylic epoxide to give the desired fused 6,3,5-tricyclic product in the
20

best yields. (40) With the formation of this tricyclic, hexahydrobenzofuranone-containing
intermediate, the subsequent transformations are easily performed to afford the
biologically active Mycorrhizin A molecule.
One final example of the application of the hexahydrobenzofuranone moiety can
be seen by the work of Ghosh and co-workers in their synthesis of a series of HIV-1
protease inhibitors which incorporate, hexahydrobenzofuranone-containing, fused
tricyclic P2 ligands. While HIV-1 protease inhibitors have always been a staple among
antiretroviral drug therapies, the rapid advancement of drug-resistance had interrupted the
clinical benefits that HIV-1 protease inhibitors can bring. (41) To combat this issue,
Ghosh and co-workers focused their inhibitory design on maximizing the active sit
interactions with protease by promoting substantial hydrogen-bonding interactions with
the backbone atoms throughout the active site. (42) Through the development of Ghosh’s
HIV-1 protease inhibitors from structure-based design targeting the protein backbone, it
was found that the syn-anti-syn-fused tricyclic P2 ligand moiety within the HIV-1
protease inhibitor was responsible for enhanced broad-range potency as well as
effectiveness against a range of multidrug-resistant HIV-1 variants. (43) (44) The
synthesis of these tricyclic P2 ligand derivatives and subsequent HIV-1 protease
inhibitor, depicted in Figure 10, shows the hexahydrobenzofuranone-containing enone
exposed to hydrogenation over 10% Pd-C in MeOH at 65 psi hydrogen pressure to afford
the resulting ketone. The reduction of the ketone with NaBH4 in MeOH followed
resulting in the endo alcohol formation shown in the bottom right of Figure 10. The
ligand alcohol was then reacted with para-nitrophenyl chloroformate and pyridine in
dichloromethane to provide mixed carbonates. The mixed carbonates were then
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transformed into the subsequent HIV-1 protease inhibitors by exposing them to the
optically active amine, labeled as molecule 6 in Figure 10, in the presence of triethyl
amine in acetonitrile. (45) The synthesized protease inhibitor derivatives were then
evaluated in antiviral assays to access their antiviral and enzymatic potencies. The
protease inhibitor at the bottom left of Figure 10 showed impressive antiviral and
enzymatic properties having an IC50 of 1.9nM. The IC50 values for each protease inhibitor
were determined via an MTT assay which assesses cell metabolic activity through
exposing tetrazolium dye MTT, usually yellow in color, to be reduced to its insoluble
formazan, qualitatively indicated by a yellow to purple color change. The protease
inhibitors developed by Ghosh and co-workers proved to maintain activity against a panel
of multidrug resistant HIV-1 variants along with giving insights into the ligand-binding
site interactions through X-ray crystal structures. As shown through the examples in this
section, hexahydrobenzofuranones are crucial organic structures as they are available for
a wide variety of organic applications and transformations, affording truly powerful
pharmaceutical agents. For this reason, it is imperative to continue to develop mild, easyto-reproduce, and economical organic conditions to afford these key structures for the
construction of pharmacophores, natural products, and thus pharmaceutical agents of the
future.
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Figure 10
Tricyclic P2 Ligand HIV-1 Protease Inhibitor Synthesis

1.3 Method Discovery
As there are many instances of the hexahydrobenzofuranone moiety featured within
key natural products and biologically active molecules, utilized in the development of
new pharmacophores, there is a continuous need for new synthetic strategies to be
developed to gain access these organic structures. To afford these crucial structures
within mild reaction procedures, the GML lab group proposed a
hexahydrobenzofuranone reaction hypothesis depicted in Table 1. The GML
hexahydrobenzofuranone reaction hypothesis begins with the bromination of
commercially bought cyclohex-2-ene-1-one in the presence of triethylamine in the
organic solvent dichloromethane. A subsequent Michael-initiated cyclopropanation
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reaction was conducted on the constructed 2-bromocyclohex-2-ene-1-one to afford the
oxobicyclo [4.1.0] heptane-7,7-dicarboxylate moiety. (54) Finally, a Lewis acid catalyzed
[3+2] cycloaddition reaction between benzaldehyde derivatives and the previously
established oxobicyclo [4.1.0] heptane-7,7-dicarboxylates to generate the
hexahydrobenzofuranone moiety. (55)

Table 1
Synthesis of Hexahydrobenzofuranone Reaction Hypothesis

1.4 Results and Discussion
As this combination of reaction procedures and organic complexes have never been
explored previously, optimization studies on this synthetic route are necessary in order to
ensure that the oxobicyclo [4.1.0] heptane-7,7-dicarboxylate products, and subsequent
synthesis of hexahydrobenzofuranones products, are constructed in the highest yielding,
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stereo- and regioselective manners. As seen in Table 2, optimization studies for the
synthesis of oxobicyclo [4.1.0] heptane-7,7-dicarboxylates began with changing the
organic solvent the reaction was run in to see which would afford the highest yields. As
dimethyl sulfoxide, DMSO, was proven to be the best choice for this reaction the reaction
concentration was then tested to optimize the appropriate amount of reaction collisions
within the organic solvent media. DMSO at a reaction molarity of 0.1M provided the best
conversion rate in this case which was confirmed by chromatographic methods such as
TLC as well as by proton and carbon NMR spectra analysis. Finally, it was important to
find the highest yielding malonic acid derivative, which acted as the Michael donor in the
cyclopropanation reaction, in order to accurately access the subsequent benzaldehyde
scope within the [3+2] cycloaddition to afford the hexahydrobenzofuranone moiety. The
optimized reaction conditions for the cyclopropanation step of the synthesis of
hexahydrobenzofuranones used ethyl 3-oxoheptanoate as the malonic acid Michael
donor, 0.1M DMSO organic solvent to promote higher yields, potassium carbonate to
promote trans-stereochemistry in the cyclopropanation product, inert reaction conditions
under elemental nitrogen gas, heating the reaction to eighty degrees Celsius on a hotplate,
and stirred for twenty-four hours which produced oxobicyclo [4.1.0] heptane-7,7dicarboxylates in 85% isolated yields. The reaction work-up, as well as the purification.
of these oxobicyclo [4.1.0] heptane-7,7-dicarboxylates was especially troublesome as
DMSO is an extremely polar solvent which made it very difficult to dry the reaction in
preparation for flash chromatography. A secondary issue encountered in this step of the
reaction was the crude TLC of each oxobicyclo [4.1.0] heptane-7,7-dicarboxylate had
four to five spots on each TLC plate of very similar Rf values, making the following flash
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chromatographic procedures exceedingly difficult. The reaction scope for the synthesis of
oxobicyclo [4.1.0] heptane-7,7-dicarboxylates can be seen in Table 5.

Table 2
Synthesis of Oxobicyclo [4.1.0] Heptane-7,7-Dicarboxylates Optimization Studies

Following the optimization of the synthesis of oxobicyclo [4.1.0] heptane-7,7dicarboxylates and the production of the oxobicyclo [4.1.0] heptane-7,7-dicarboxylate
reaction scope, the optimization of the final step of the synthesis of
hexahydrobenzofuranones was began by using the ethyl 2-oxo-7-pentanoyl bicyclo
[4.1.0] heptane-7-carboxylate as the oxobicyclo [4.1.0] heptane-7,7-dicarboxylates
precursor for the Lewis acid catalyzed [3+2] cycloaddition reaction. For this reaction
step, dichloromethane and dichloroethane were used as organic solvents with a variety of
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reaction concentrations to access the best yielding reaction. It was found that
dichloroethane with a solvent concentration of 0.1M, using the 4-pyridine
carboxaldehyde afforded the best yield to produce the hexahydrobenzofuranone moiety.
The mechanism for the final step of the synthesis of hexahydrobenzofuranones is thought
to occur via a Lewis acid induced dipole along the carbonyl of the benzaldehyde
derivative, causing the benzaldehyde to act as nucleophile, inducing an inversion of
stereochemistry at the C2 carbon of the cyclopropane ring of the ethyl 2-oxo-7-pentanoyl
bicyclo [4.1.0] heptane-7-carboxylate structure. This inversion of stereochemistry of the
C2 carbon opens the cyclopropane ring in the ethyl 2-oxo-7-pentanoyl bicyclo [4.1.0]
heptane-7-carboxylate structure allowing for the [3+2] cycloaddition to then occur.
Challenges were met with the purification of the hexahydrobenzofuranones as
diastereomeric forms of hexahydrobenzofuranones were produced from the reaction
having Rf values, by crude TLC, that were almost identical. Table 6 shows the afforded
reaction scope of the hexahydrobenzofuranones produced.
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Table 3
Synthesis of Hexahydrobenzofuranone Optimization Studies

While the novel synthesis of hexahydrobenzofuranones has been afforded by the
GML lab group, there are still other complimentary synthetic routes to be explored,
through future organic synthetic endeavors, to afford fused bicyclic organic constructs
from the oxobicyclo [4.1.0] heptane-7,7-dicarboxylate derivatives generated in the GML
novel synthetic strategy. As seen in Table 6, nitrones, diaziridines, cyclic alkynes, imines,
oxaziridines, isocyanates, and nitriles can be used in place of the benzaldehyde
derivatives to form these bridged heterocycles through novel synthetic strategies. With
this collection of fused bicyclic structures, a multitude of transformations can be tested in
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order to form crucial pharmacophores, which are likely to have biologically active,
through mild, novel reaction conditions.
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Table 4
Synthesis of Oxobicyclo [4.1.0] Heptane-7,7-Dicarboxylates Reaction Scope
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Table 5
Synthesis of Hexahydrobenzofuranones Reaction Scope
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Table 6
Future Endeavors for Synthesis of Fused Heterocyclic Complexes

1.5 Conclusion
Using the optimized novel synthetic conditions developed by the GML lab group, a
diastereoselective, efficient, and convergent approach towards the selective synthesis of
fused-cyclic hexahydrobenzofuranones from oxobicyclo [4.1.0] heptane-7,7dicarboxylates and aldehydes have been developed under mild Lewis acid reaction
conditions. The novel synthesis of hexahydrobenzofuranones has shown to occur under a
wide variety of substitution patterns along with producing complex organic products in
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high yields. This reaction provides competent access to highly functionalized
heterocyclic structures from simple-to-synthesize scaffolds allowing for future synthetic
approaches towards more complex heterocyclic pharmacophores. A large variety of
derivative synthetic routes have also begun development, using this novel synthesis for
foundational knowledge, to apply these synthetic strategies towards the creation of a wide
variety of fused-cyclic complexes.
1.6 Experimental
Organic reagents were obtained from Aldrich Chemical, Acros Organics, and Alfa
Aesar. Organic reactions were performed with 20 milliliter glass vials that allowed for
magnetic stirring. TLC analysis was performed via a 0.25mm E. Merck silica gel 60 F254
plates and visualized under 254 nm UV light as well as staining with potassium
permanganate solution (KMnO4). Products were purified via manual silica-gel flash
chromatography and collected based on NMR analysis and Rf values of UV spots by
TLC. NMR spectrum were recorded via Varian Mercury II 400 MHz Spectrometer at 24
degrees Celsius in CDCl. Chemical shifts are expressed in ppm relative to solvent
signals: CDCl, (1 H, 7.23 ppm; 13C, 77.0ppm; coupling constants expressed in Hz)
1.6.1 General Method for Synthesis of Oxobicyclo [4.1.0] Heptane-7,7-Dicarboxylates
The procedures for the first step in the synthesis of the functionalized
hexahydrobenzofuran-4(2H)-one products is bromination of commercially bought
cyclohexa-2-en-1-one into 2-bromocyclohex-2-en-1-one. To set up this first step
bromination reaction, the solvent dichloromethane (DCM) was added into a round bottom
to stir in an ice bath; enough DCM was added to achieve a reaction concentration of
0.1M. Once the solvent was cooled to zero degrees Celsius, 1.1 equivalence of elemental
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bromine (Br2) was added dropwise followed by dropwise addition of 1.1 equivalence
triethylamine. The reaction was left to stir overnight for workup the following day. The
reaction was worked up via liquid/liquid extraction with a polar solvent, such as ethyl
acetate, and the organic layer was then collected. The organic layer was washed with
saturated sodium bicarbonate solution, water, and finally brine. The organic layer was
then dried with sodium sulfate followed by gravity filtration, drying of solvent via
rotatory evaporation, and finally analysis/confirmation of product of first step product via
proton/carbon NMR, infrared spectroscopy (IR), and mass spectrometry (MS). Once 2bromocyclohex-2-en-1-one was confirmed via analysis, the set up for the second step of
the synthesis of functionalized hexahydrobenzofuran-4(2H)-one was begun.
The procedures for the second step of the synthesis of functionalized
hexahydrobenzofuran-4(2H)-ones aimed to transform pure, crystalized 2-bromocyclohex2-en-1-one into 1,1'-(2-oxobicyclo[4.1.0]heptane-7,7-diyl)bis(ethan-1-one), which is
depicted on the top right of the substrate synthesis schematic in figure 2. Pure, crystalized
2-bromocyclohex-2en-1-one was weighed to the reaction scale and added into the organic
solvent dimethyl sulfoxide, (DMSO), to create a reaction concentration of 0.1M. Two
equivalences of potassium carbonate were then added into the reaction vial and a rubber
stopper was secured to the top of the 20 mL reaction vial via parafilm. The reaction vial
was then made inert with elemental nitrogen gas (N2) and the nitrogen gas was
continuous run through the reaction vial while the pentane-2,4-dione was syringed into
the stirring reaction. The reaction stirred overnight at 80º Celsius for workup the
following day.
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The reaction was taken off the heat and allowed to cool to room temperature
followed by gravity filtration. Liquid-liquid extraction was performed on the resulting
product solution with 3:1 ratio of ethyl acetate (EtoAc) to di methyl sulfoxide (DMSO)
reaction solution and the ethyl acetate layer was collected. The ethyl acetate organic layer
was washed with water twice and dried with sodium sulfate followed by gravity filtration.
The crude product organic solution was rotatory evaporated down and the resulting crude
oil was characterized/confirmed by proton and carbon NMR, infrared spectroscopy (IR),
and mass spectrometry (MS). Once the crude product was confirmed, manual, silicabased, flash column chromatography was performed to isolate the pure second step
product shown in the top right of figure 2. The pure second step product was
characterized/confirmed via proton/carbon NMR, infrared spectroscopy (IR), and mass
spectrometry (MS). Once the creation of one of the 1,1'-(2-oxobicyclo [4.1.0] heptane7,7-diyl) bis(ethan-1-one) products were confirmed, the third and final step of the
synthesis of functionalized hexahydrobenzofuran-4(2H)-ones were set up.
1.6.2 General Method for the Synthesis of Hexahydrofuranones
Each pure 1,1'-(2-oxobicyclo [4.1.0] heptane-7,7-diyl) bis(ethan-1-one) product,
of the second step of the functionalized hexahydrobenzofuran-4(2H)-ones synthesis, was
added to a stock solution of the solvent dichloroethane (DCE) under elemental nitrogen
gas. Inert dichloroethane was poured into a clean 250 mL round bottom under argon gas,
via an inert solvent dispenser, and a rubber stopper was placed to cap the round bottom.
Elemental nitrogen gas was set to flow throw the round bottom and out of a syringe vent
in the rubber stopper. The scaled number of milliliters of pure 1,1'-(2-oxobicyclo [4.1.0]
heptane-7,7-diyl) bis(ethan-1-one) product dichloroethane stock solution was added into
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the 250-milliliter round bottom while the elemental nitrogen gas was running through the
round bottom. The aldehyde was then syringed into the 250-milliliter round bottom while
the nitrogen gas was still running and finally the triflic acid was diluted to 10 mol %
stock solution of dry dichloroethane under argon and was then carefully syringed into the
250 mL reaction round bottom. Positive pressure was added to the round bottom by
removing the vent syringe and then the nitrogen gas syringe a few seconds later. The
reaction was run overnight. Once the crude product was confirmed, manual, silica-based,
flash column chromatography was performed to isolate the pure final step product shown
in Figure 2. The pure final step of the synthesis of hexahydrobenzofuran-4(2H)-ones was
characterized/confirmed via proton/carbon NMR, infrared spectroscopy (IR), and mass
spectrometry (MS).
1.6.3 Synthesis of Hexahydrobenzofuranones From Table 4 & 5

JDH-11-2c
Ethyl 7-(4-methylbenzoyl)-2-oxobicyclo[4.1.0]heptane-7-carboxylate (2c):
Purification via manual silica gel flash chromatography (20:1 heptanes/EtOAc to 1:1
heptanes/EtOAc) afforded the oxobicyclo [4.1.0] heptane-7,7-dicarboxylates product 2c
(86% yield) as an amber oil. 1H NMR: (400 MHz, Chloroform-d) δ 1.28 (3H, t, J = 7.1
Hz), 1.66-1.95 (5H, 1.74 (dtdd, J = 13.4, 10.2, 2.9, 2.3 Hz), 1.76 (dddd, J = 13.1, 7.9, 2.9,
2.6 Hz), 1.77 (dddd, J = 13.1, 10.2, 3.2, 2.8 Hz), 1.82 (ddd, J = 8.1, 7.9, 2.8 Hz), 1.87
(ddddd, J = 13.4, 3.3, 3.2, 2.6, 2.2 Hz)), 2.18 (1H, d, J = 8.1 Hz), 2.32-2.58 (2H, 2.39
(ddd, J = 14.6, 3.3, 2.3 Hz), 2.50 (ddd, J = 14.6, 10.2, 2.2 Hz)), 3.79 (3H, s), 4.09-4.20
(2H, 4.14 (q, J = 7.1 Hz), 4.14 (q, J = 7.1 Hz)), 7.08 (2H, ddd, J = 8.3, 1.2, 0.4 Hz), 8.02
(2H, ddd, J = 8.3, 1.8, 0.4 Hz).
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JDH-91-2d
Ethyl 7-(4-nitrobenzoyl)-2-oxobicyclo[4.1.0]heptane-7-carboxylate (2d): Purification
via manual silica gel flash chromatography (20:1 heptanes/EtOAc to 1:1 heptanes
/EtOAc) afforded the oxobicyclo [4.1.0] heptane-7,7-dicarboxylates product 2d (60%
yield) as an amber oil. 1H NMR: (400 MHz, Chloroform-d) 1H NMR: δ 1.28 (3H, t, J =
7.1 Hz), 1.66-1.95 (5H, 1.74 (dtdd, J = 13.4, 10.2, 2.9, 2.3 Hz), 1.76 (dddd, J = 13.1, 7.9,
2.9, 2.6 Hz), 1.77 (dddd, J = 13.1, 10.2, 3.2, 2.8 Hz), 1.82 (ddd, J = 8.1, 7.9, 2.8 Hz), 1.87
(ddddd, J = 13.4, 3.3, 3.2, 2.6, 2.2 Hz)), 2.20 (1H, d, J = 8.1 Hz), 2.32-2.58 (2H, 2.39
(ddd, J = 14.6, 3.3, 2.3 Hz), 2.50 (ddd, J = 14.6, 10.2, 2.2 Hz)), 4.09-4.20 (2H, 4.14
(q, J = 7.1 Hz), 4.14 (q, J = 7.1 Hz)), 7.80 (2H, ddd, J = 8.6, 1.5, 0.5 Hz), 8.17 (2H,
ddd, J = 8.6, 1.8, 0.5 Hz).

JDH-103-2f
Ethyl 2-oxo-7-pentanoylbicyclo[4.1.0]heptane-7-carboxylate (2f): Purification via
manual silica gel flash chromatography (20:1 heptanes/EtOAc to 1:1 heptanes/EtOAc)
afforded the oxobicyclo [4.1.0] heptane-7,7-dicarboxylates product 2f (90% yield) as an
amber oil. 1H NMR: (400 MHz, Chloroform-d) δ 0.88 (3H, t, J = 6.5 Hz), 1.21-1.37 (5H,
1.28 (tq, J = 7.0, 6.5 Hz), 1.28 (tq, J = 7.0, 6.5 Hz), 1.31 (t, J = 7.1 Hz)), 1.47-1.61 (2H,
1.54 (tt, J = 7.4, 7.0 Hz), 1.54 (tt, J = 7.4, 7.0 Hz)), 1.65-1.95 (5H, 1.74 (dddd, J = 13.0,
7.9, 2.9, 2.6 Hz), 1.74 (dtdd, J = 13.4, 10.2, 2.9, 2.3 Hz), 1.78 (dddd, J = 13.0, 10.2, 3.2,
2.8 Hz), 1.81 (ddd, J = 8.1, 7.9, 2.8 Hz), 1.87 (ddddd, J = 13.4, 3.3, 3.2, 2.6, 2.2 Hz)),
2.19 (1H, d, J = 8.1 Hz), 2.32-2.58 (4H, 2.40 (ddd, J = 14.6, 3.3, 2.3 Hz), 2.49 (ddd, J =
14.6, 10.2, 2.2 Hz), 2.52 (t, J = 7.4 Hz), 2.52 (t, J = 7.4 Hz)), 4.08-4.20 (2H, 4.14 (q, J =
7.1 Hz), 4.14 (q, J = 7.1 Hz)).

JDH-78-3a
2-pyridine-3-(methoxymethyl)-3-pentanoylhexahydro-1-benzofuran-4(2H)-one—
formaldehyde (3a): Purification via manual silica gel flash chromatography (20:1
heptanes/EtOAc to 4:1 heptanes/EtOAc) afforded the hexahydrobenzofuranone product
3a (80% yield) as an amber oil. 1H NMR: (400 MHz, Chloroform-d) δ 0.88 (3H, t, J =
6.5 Hz), 1.23-1.34 (2H, 1.28 (h, J = 6.5 Hz), 1.28 (h, J = 6.5 Hz)), 1.46-1.75 (4H, 1.52
(tt, J = 7.4, 6.5 Hz), 1.52 (tt, J = 7.4, 6.5 Hz), 1.62 (dtdd, J = 13.1, 10.2, 3.1, 2.4 Hz), 1.68
(dddt, J = 13.1, 3.2, 3.1, 2.5 Hz)), 1.79-2.03 (2H, 1.88 (dddd, J = 14.5, 10.2, 2.8, 2.5 Hz),
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1.96 (dddd, J = 14.5, 3.2, 2.9, 2.4 Hz)), 2.38-2.57 (4H, 2.46 (ddd, J = 14.9, 3.1, 2.5 Hz),
2.48 (ddd, J = 14.9, 10.3, 3.1 Hz), 2.51 (t, J = 7.4 Hz), 2.51 (t, J = 7.4 Hz)), 3.49 (1H,
d, J = 4.8 Hz), 3.76 (3H, s), 4.22 (1H, ddd, J = 4.8, 2.9, 2.8 Hz), 5.75 (1H, s), 7.17 (2H,
ddd, J = 4.8, 1.5, 0.5 Hz), 8.56 (2H, ddd, J = 4.8, 1.9, 0.5 Hz).

JDH-59-3b
2-furan-3-(methoxymethyl)-3-pentanoylhexahydro-1-benzofuran-4(2H)-one—
formaldehyde (3b): Purification via manual silica gel flash chromatography (20:1
heptanes/EtOAc to 4:1 heptanes/EtOAc) afforded the hexahydrobenzofuranone product
3b (84% yield) as an amber oil. 1H NMR: δ 0.88 (3H, t, J = 6.5 Hz), 1.22-1.35 (2H, 1.28
(tq, J = 6.6, 6.5 Hz), 1.28 (tq, J = 6.6, 6.5 Hz)), 1.46-1.75 (4H, 1.52 (tt, J = 7.4, 6.6 Hz), 1.52
(tt, J = 7.4, 6.6 Hz), 1.62 (dtdd, J = 13.1, 10.2, 3.1, 2.4 Hz), 1.67 (dddt, J = 13.1, 3.2, 3.1, 2.5 Hz)),
1.79-2.03 (2H, 1.88 (dddd, J = 14.5, 10.2, 2.8, 2.5 Hz), 1.95 (dddd, J = 14.5, 3.2, 2.9, 2.4 Hz)),
2.38-2.57 (4H, 2.45 (ddd, J = 14.9, 3.1, 2.5 Hz), 2.48 (ddd, J = 14.9, 10.3, 3.1 Hz), 2.51 (t, J = 7.4
Hz), 2.51 (t, J = 7.4 Hz)), 3.62 (1H, d, J = 4.8 Hz), 3.76 (3H, s), 4.19 (1H, ddd, J = 4.8, 2.9, 2.8
Hz), 5.23 (1H, s), 6.18-6.33 (2H, 6.23 (dd, J = 3.4, 1.1 Hz), 6.27 (dd, J = 3.4, 1.8 Hz)), 7.40 (1H,
dd, J = 1.8, 1.1 Hz).

JDH-99-3c
2-(1-nitrobenzene)-3-(methoxymethyl)-3-pentanoylhexahydro-1-benzofuran-4(2H)one—formaldehyde (3c): Purification via manual silica gel flash chromatography (20:1
heptanes/EtOAc to 4:1 heptanes/EtOAc) afforded the hexahydrobenzofuranone product
3c (65% yield) as an amber oil. 1H NMR: δ 0.88 (3H, t, J = 6.5 Hz), 1.23-1.34 (2H, 1.28
(h, J = 6.5 Hz), 1.28 (h, J = 6.5 Hz)), 1.46-1.75 (4H, 1.53 (tt, J = 7.4, 6.5 Hz), 1.53 (tt, J = 7.4, 6.5
Hz), 1.62 (dtdd, J = 13.1, 10.2, 3.1, 2.4 Hz), 1.68 (dddt, J = 13.1, 3.2, 3.1, 2.5 Hz)), 1.79-2.04 (2H,
1.88 (dddd, J = 14.5, 10.2, 2.8, 2.5 Hz), 1.96 (dddd, J = 14.5, 3.2, 2.9, 2.4 Hz)), 2.38-2.57 (4H,
2.46 (ddd, J = 14.9, 3.1, 2.5 Hz), 2.48 (ddd, J = 14.9, 10.3, 3.1 Hz), 2.51 (t, J = 7.4 Hz), 2.51
(t, J = 7.4 Hz)), 3.51 (1H, d, J = 4.8 Hz), 3.76 (3H, s), 4.11 (1H, ddd, J = 4.8, 2.9, 2.8 Hz), 5.74
(1H, s), 7.55 (1H, ddd, J = 8.3, 7.7, 1.7 Hz), 7.67-7.87 (2H, 7.73 (td, J = 7.7, 1.7 Hz), 7.81
(ddd, J = 7.6, 1.7, 0.5 Hz)), 8.09 (1H, ddd, J = 8.3, 1.7, 0.5 Hz).

JDH-65-3d
3-napthalene-3-(methoxymethyl)-3-pentanoylhexahydro-1-benzofuran-4(2H)-one—
formaldehyde (3d): Purification via manual silica gel flash chromatography (20:1
heptanes/EtOAc to 4:1 heptanes/EtOAc) afforded the hexahydrobenzofuranone product
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3d (75% yield) as an amber oil. 1H NMR: δ 0.88 (3H, t, J = 6.5 Hz), 1.23-1.34 (2H, 1.29
(h, J = 6.5 Hz), 1.29 (h, J = 6.5 Hz)), 1.46-1.75 (4H, 1.53 (tt, J = 7.4, 6.5 Hz), 1.53 (tt, J =
7.4, 6.5 Hz), 1.61 (dtdd, J = 13.0, 10.2, 3.1, 2.4 Hz), 1.68 (dddt, J = 13.0, 3.2, 3.1, 2.5
Hz)), 1.76-2.08 (2H, 1.85 (dddd, J = 14.5, 10.2, 2.8, 2.5 Hz), 2.00 (dddd, J = 14.5, 3.2,
2.9, 2.4 Hz)), 2.39-2.61 (4H, 2.47 (ddd, J = 14.9, 3.1, 2.5 Hz), 2.52 (ddd, J = 14.9, 10.3,
3.1 Hz), 2.51 (t, J = 7.4 Hz), 2.51 (t, J = 7.4 Hz)), 3.54 (1H, d, J = 4.8 Hz), 3.76 (3H, s),
4.15 (1H, ddd, J = 4.8, 2.9, 2.8 Hz), 5.38 (1H, s), 7.37 (1H, dddd, J = 8.0, 6.9, 1.8, 0.5
Hz), 7.44-7.69 (3H, 7.51 (ddd, J = 9.7, 8.0, 0.5 Hz), 7.59 (ddd, J = 8.5, 6.9, 1.7 Hz), 7.62
(ddd, J = 9.7, 1.8, 0.5 Hz)), 7.85-8.05 (3H, 7.91 (dddt, J = 8.0, 2.6, 1.8, 0.5 Hz), 7.93
(dddt, J = 8.0, 2.6, 1.7, 0.5 Hz), 7.98 (ddq, J = 8.5, 1.8, 0.5 Hz)).

JDH-95-3f
3-(3,4 dichlorobenzene)-3-(methoxymethyl)-3-pentanoylhexahydro-1-benzofuran4(2H)-one—formaldehyde (3f): Purification via manual silica gel flash chromatography
(20:1 heptanes/EtOAc to 4:1 heptanes/EtOAc) afforded the hexahydrobenzofuranone
product 3f (75% yield) as an amber oil. 1H NMR: δ 0.88 (3H, t, J = 6.5 Hz), 1.23-1.34 (2H,
1.28 (h, J = 6.5 Hz), 1.28 (h, J = 6.5 Hz)), 1.46-1.75 (4H, 1.53 (tt, J = 7.4, 6.5 Hz), 1.53 (tt, J = 7.4,
6.5 Hz), 1.62 (dtdd, J = 13.1, 10.2, 3.1, 2.4 Hz), 1.68 (dddt, J = 13.1, 3.2, 3.1, 2.5 Hz)), 1.79-2.04
(2H, 1.88 (dddd, J = 14.5, 10.2, 2.8, 2.5 Hz), 1.96 (dddd, J = 14.5, 3.2, 2.9, 2.4 Hz)), 2.38-2.57
(4H, 2.46 (ddd, J = 14.9, 3.1, 2.5 Hz), 2.48 (ddd, J = 14.9, 10.3, 3.1 Hz), 2.50 (t, J = 7.4 Hz), 2.50
(t, J = 7.4 Hz)), 3.50 (1H, d, J = 4.8 Hz), 3.76 (3H, s), 4.11 (1H, ddd, J = 4.8, 2.9, 2.8 Hz), 5.33
(1H, s), 7.32 (1H, dd, J = 8.3, 1.9 Hz), 7.49-7.71 (2H, 7.55 (dd, J = 8.3, 0.5 Hz), 7.66 (dd, J = 1.9,
0.5 Hz)).

JDH-64-3g
3-(2-bromobenzene)-3-(methoxymethyl)-3-pentanoylhexahydro-1-benzofuran4(2H)-one—formaldehyde (3g): Purification via manual silica gel flash chromatography
(20:1 heptanes/EtOAc to 4:1 heptanes/EtOAc) afforded the hexahydrobenzofuranone
product 3g (65% yield) as an amber oil. 1H NMR: δ 0.88 (3H, t, J = 6.5 Hz), 1.23-1.34
(2H, 1.28 (h, J = 6.5 Hz), 1.28 (h, J = 6.5 Hz)), 1.46-1.75 (4H, 1.53 (tt, J = 7.4, 6.5 Hz),
1.53 (tt, J = 7.4, 6.5 Hz), 1.62 (dtdd, J = 13.1, 10.2, 3.1, 2.4 Hz), 1.68 (dddt, J = 13.1, 3.2,
3.1, 2.5 Hz)), 1.79-2.04 (2H, 1.88 (dddd, J = 14.5, 10.2, 2.8, 2.5 Hz), 1.96 (dddd, J =
14.5, 3.2, 2.9, 2.4 Hz)), 2.38-2.57 (4H, 2.46 (ddd, J = 14.9, 3.1, 2.5 Hz), 2.48 (ddd, J =
14.9, 10.3, 3.1 Hz), 2.51 (t, J = 7.4 Hz), 2.51 (t, J = 7.4 Hz)), 3.50 (1H, d, J = 4.8 Hz),
3.76 (3H, s), 4.11 (1H, ddd, J = 4.8, 2.9, 2.8 Hz), 5.31 (1H, s), 6.95 (1H, ddd, J = 8.0, 1.7,
1.2 Hz), 7.24-7.42 (2H, 7.30 (ddd, J = 8.0, 1.7, 1.5 Hz), 7.36 (td, J = 8.0, 0.5 Hz)), 7.58
(1H, ddd, J = 1.5, 1.2, 0.5 Hz).
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JDH-63-3h
3-toluene-3-(methoxymethyl)-3-pentanoylhexahydro-1-benzofuran-4(2H)-one—
formaldehyde (3h): Purification via manual silica gel flash chromatography (20:1
heptanes/EtOAc to 4:1 heptanes/EtOAc) afforded the hexahydrobenzofuranone product
3h (71% yield) as an amber oil. 1H NMR: δ 0.88 (3H, t, J = 6.5 Hz), 1.23-1.34 (2H, 1.28
(h, J = 6.5 Hz), 1.28 (h, J = 6.5 Hz)), 1.46-1.75 (4H, 1.53 (tt, J = 7.4, 6.5 Hz), 1.53 (tt, J =
7.4, 6.5 Hz), 1.62 (dtdd, J = 13.1, 10.2, 3.1, 2.4 Hz), 1.68 (dddt, J = 13.1, 3.2, 3.1, 2.5
Hz)), 1.79-2.04 (2H, 1.88 (dddd, J = 14.5, 10.2, 2.8, 2.5 Hz), 1.96 (dddd, J = 14.5, 3.2,
2.9, 2.4 Hz)), 2.27 (3H, s), 2.38-2.57 (4H, 2.46 (ddd, J = 14.9, 3.1, 2.5 Hz), 2.48 (ddd, J =
14.9, 10.3, 3.1 Hz), 2.51 (t, J = 7.4 Hz), 2.51 (t, J = 7.4 Hz)), 3.50 (1H, d, J = 4.8 Hz),
3.76 (3H, s), 4.10 (1H, ddd, J = 4.8, 2.9, 2.8 Hz), 5.38 (1H, s), 7.16-7.35 (4H, 7.22
(ddd, J = 8.0, 1.2, 0.5 Hz), 7.29 (ddd, J = 8.0, 0.9, 0.5 Hz)).

JDH-61-3i
3-(2-chlorbenzene)-3-(methoxymethyl)-3-pentanoylhexahydro-1-benzofuran-4(2H)one—formaldehyde (3i): Purification via manual silica gel flash chromatography (20:1
heptanes/EtOAc to 4:1 heptanes/EtOAc) afforded the hexahydrobenzofuranone product
3i (74% yield) as an amber oil. 1H NMR: δ 0.88 (3H, t, J = 6.5 Hz), 1.23-1.34 (2H, 1.28
(h, J = 6.5 Hz), 1.28 (h, J = 6.5 Hz)), 1.46-1.75 (4H, 1.53 (tt, J = 7.4, 6.5 Hz), 1.53 (tt, J =
7.4, 6.5 Hz), 1.62 (dtdd, J = 13.1, 10.2, 3.1, 2.4 Hz), 1.68 (dddt, J = 13.1, 3.2, 3.1, 2.5
Hz)), 1.79-2.04 (2H, 1.88 (dddd, J = 14.5, 10.2, 2.8, 2.5 Hz), 1.96 (dddd, J = 14.5, 3.2,
2.9, 2.4 Hz)), 2.38-2.57 (4H, 2.46 (ddd, J = 14.9, 3.1, 2.5 Hz), 2.48 (ddd, J = 14.9, 10.3,
3.1 Hz), 2.51 (t, J = 7.4 Hz), 2.51 (t, J = 7.4 Hz)), 3.50 (1H, d, J = 4.8 Hz), 3.76 (3H, s),
4.11 (1H, ddd, J = 4.8, 2.9, 2.8 Hz), 5.32 (1H, s), 7.07 (1H, ddd, J = 8.0, 1.5, 1.4 Hz),
7.25 (1H, dt, J = 8.1, 1.6 Hz), 7.33-7.57 (2H, 7.40 (ddd, J = 8.1, 8.0, 0.5 Hz), 7.52
(ddd, J = 1.6, 1.4, 0.5 Hz)).
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1.6.4 Synthesis of Hexahydrobenzofuranones – 1H NMR Spectra
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Chapter 2
Selective Synthesis of Pyrrolidines, Pyrrolines, and Azepines
From Haloaziridines

Pyrrolidines, pyrrolines, and azepines and their derivatives are critically important
classes of heterocyclic compounds that contain one nitrogen atom. The GML lab group is
interested in the development of novel methodologies for the synthesis of these key
organic skeletons and, more specifically, the selective synthesis of halogenated nitrogen
containing heterocyclic compounds from haloaziridine precursors. Pyrrolidines, also
known by the chemical name tetrahydropyrrole, are a class of organic compounds which
are characterized by a pentane ring containing four carbons and one nitrogen.
Pyrrolidines have the chemical formula C4H9N and the molecular formula (CH2)4NH.
Pyrrolines and its isomeric forms, 1-pyrroline, 2-pyrroline, and 3-pyrroline are a class of
organic compounds distinguished by a pentane ring containing four carbon atoms and one
nitrogen atom with the chemical formula C4H7N. Azepines are denoted by a heptane ring
containing six carbon atoms and one nitrogen atm and have the chemical formula
C6H11N. Figure 11 illustrates, pyrroline, azepine, and pyrrolidine respectively from left to
right, the nitrogen containing heterocyclic target moieties previously mentioned that will
be discussed in this chapter. The general synthesis routes and applications of each organic
moiety, pyrroline, pyrrolidine, and azepine, will be touched upon in the following section
but synthesizing halogenated versions of these nitrogen-containing heterocycles will be
the major focus of this chapter as these are the GML lab groups focus for this endeavor.
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Figure 11
Pyrroline, Pyrrolidine, and Azepine Moiety

2.1 Synthesis of Pyrrolidines, Azepines, and Pyrrolines
When studying various organic methods designed to synthesize a target moiety in
mind, it is crucial to locate one of the first examples of the synthesis of the target moiety
to receive insight into where the development of these compounds began. One of the first
methods to synthesize pyrrolines and pyrrolidines was completed by Bucherer and Seyde
in 1908 by reacting 3-hydroxy-2-naphthoic acid with phenyl hydrazine in the presence of
sodium bisulfate under reflux for 18 hours. This procedure afforded pyrroline-containing,
sodium salt of benzo-carbazole sulfonic acid as a yellow crystalline mass in 75% yield.
(46) An initial synthetic route to bear azepine-containing moieties was for the multi-step
synthesis of substituted tetrahydrobenzazepines by Bobowski and co-workers in 1979.
The substituted tetrahydrobenzazepines are important organic moieties as they were
found to exhibit arrhythmic activity in an ouabain-induced arrythmia. (47) To begin this
synthesis route, arylaldehydes and 2-nitropropanes were run through a condensation
reaction to generate nitro-alcohols which were then reduced to alcohol amines catalyzed
by zinc and acetic acid. Another condensation reaction was run between the provided
nitro-alcohols and arylacetaldehydes to give an imino complex derivative which was
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reduced with borohydride to achieve a secondary amine complex. Finally, the secondary
amine complex was reacted with various mineral acids to complete the final cyclization
reaction to give the tetrahydrobenzazepines derivative. (48)
Now that initial synthetic examples of pyrroline, pyrrolidine, and azepines have
been given, general synthetic routes to afford these moieties will be considered along
with, in the following section, synthetic methods that grant the ability to produce
halogenated pyrroline, pyrrolidine, and azepine moieties. The synthesis of pyrrolines and
pyrrolidines will be briefly discussed by reviewing current organic methods including
catalytic and non-catalytic cyclization reactions, ring expansion reactions, ring close
metathesis and a few other instances. (49) In the first general synthetic method of
catalytic/non-catalytic cyclization reactions, an efficient aza-Cope-Mannich cyclization
was presented by Ruben and coworkers in which 2-hydroyl homoallyl tosylamine and
aldehydes were reacted in the presence of iron(III) salts to afford 3-alkyl-1-tosyl
pyrrolines in good yields. This cyclization process involved the generation of a γunsaturated iminium ion followed by a sigmatropic rearrangement and finally an
intramolecular Mannich reaction. (50) Iron (III) salts are shown in Ruben’s work to be
excellent catalysts for new aza-Cope-Mannich cyclization using 2-hydroxy
homopropargyl tosylamine.
Liang Y and collaborators have also developed an efficient one-pot
synthesis of substituted pyrrolines in aqueous media. This method involves the treatment
of a range of various chalcone derivatives with aqueous sodium hydroxide in N,Ndimethylformamide to undergo a room temperature Michael addition reaction with
nitroalkanes. The resulting adducts were then directly reduced in situ with Zn/HCl which
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induced intramolecular cyclization generating the corresponding substituted pyrrolines in
high yields. (51) A non-catalytic cyclization reaction to afford the pyrroline moiety was
completed by Ohno and colleagues in which alpha amino allenes bearing an amino
protecting group were reacted with potassium carbonate in DMF under reflex without the
presence of a transition-metal catalyst giving the corresponding 3-pyrrolines in excellent
yields. This non-catalytic cyclization reaction occurred via an endo-trig
cycloisomerization as internal allenes with axial chirality were able to form the 3pyrrolines in a stereoselective manner. (52)
Kumar and colleagues have reported the synthesis of pyrrolines through a
ring expansion reaction using aziridines as molecular precursors. In this organic
procedure, silver nitrate and chloramine-T were used for the transformation of alkene
derivatives into the respective aziridines. The rendered aziridines were reacted in the ring
expansion reaction with acrylo-nitrile and ethyl acrylate using solid sodium hydroxide as
the base in the organic solvent tetrahydrofuran to bear 1-pyrrolines in 40-58% yields.
(THF) (56)
Pyrrolidines have also been afforded through catalytic cyclization reactions
such as in the Hofmann-Loffler-Freytag reaction. In this organic procedure, cyclic amines
are generated through thermal or photo-chemical decomposition of N-halogenated amine
in the presence of a strong acid such as triflic acid or sulfuric acid. This reaction occurs
via intramolecular hydrogen atom transfer of the N-halogenated amine to a nitrogencentered radical which enables intramolecular free radical C-H functionalization and
cyclization, under basic conditions, to yield pyrrolidines. (49)
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Another two catalytic cyclization reactions to afford pyrrolidines can be
found in a one-pot synthesis routes depicted in Figure 12. The first one-pot pyrrolidine
synthesis route, shown at the top of Figure 12, uses an amino alcohol to go through a
halogenation-cyclization reaction which is induced by 3 equivalences of thionyl chloride
in the organic solvent dimethyl ethane at room temperature for two to six hours. (53) The
second one-pot pyrrolidine synthesis, shown at the bottom of Figure 12, reacts
dihaloalkanes with alkyl and aryl amines separately in the presence of 1.1 equivalences of
potassium chloride under 70-100W of microwave irradiation at 120 degrees Celsius for
20 minutes to produce pyrrolidines. (57)

Figure 12
One-Pot Synthesis of Pyrrolidines
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Yang, Alper, and Xiao have displayed an efficient manner for the synthesis
of chiral pyrrolidines via a ring-closing enyne metathesis. To complete this reaction, 1
mmol of enyne precursor was dissolved into 17 milliliters of freshly distilled and
degassed dichloromethane under elemental nitrogen gas. Positive pressure was induced
with nitrogen gas syringed into the reaction vial and the reaction stirred for 10 minutes in
reflux. A ruthenium catalyst was then syringed into the reaction vial and the reaction was
left to run for 14-20 hours in reflux to generate the respective chiral pyrrolidines. (58)
Metal catalyzed cyclization and cycloaddition reactions have also been
presented to impart the production of complex pyrrolidines. Shi and co-workers have
prepared synthesized pyrrolidines through a gold catalyzed reaction between methylene
cyclopropanes and sulfonamide in toluene at 85 degrees Celsius. (59) In another metal
catalyzed cyclization reaction to afford pyrrolidines occurred from Komeyama and
colleagues through hydroamination via inactivated olefins. These olefins are activated by
by iron (III) chloride in dichloroethane at 80 degrees Celsius for 2-38 hours producing
pyrrolidines in an efficient manner. (60)
Now that a brief overview at the current methods to synthesize both
pyrrolines and pyrrolidines have been discussed, the focus will now turn to the synthesis
of azepines that are currently available. Azepines have been synthesized by a multitude of
groups using organic methods such as insertion reactions, cyclo-expansion reaction, ringclosing metathesis, and many more. (61) In the first synthetic example of azepines,
depicted in Figure 13, shows intermolecular insertion of nitrenes across a benzene double
bond at high temperature and pressure to produce the ring-expanded product Hsoulfonyl-1H-azepine.This thermolysis reaction of toluene-9-sulfonyl azide was
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performed with excess benzene under high nitrogen pressure at 155 to 160 degrees
Celsius and afforded side products in miniscule yields. (62)

Figure 13
Azepine Synthesis via Nitrene and Benzene Insertion Reaction

Another insertion rection between nitrene and benzene was generated in situ
through reaction of phenyl nitrene and benzene. This reaction undergoes an addition
reaction to form an intermediate which then catalyzes the insertion reaction to afford the
N-phenyl-1H-azepines in high yields. (63) Conjugative addition of secondary formamide
to nitroalkenes gives INOC precursors within 2-4 hours in yet another synthetic strategy
to afford azepines. The intramolecular nitrile oxide cycloaddition, INOC, precursors are
exposed to phenyl isocyanate under basic conditions and afford nitrile oxides which
immediate react with internal alkenes to give bicyclic isoxazole-fused azepines in fair
yields. (64)
One final example of a synthetic strategy to afford azepine moieties is
through ring closing metathesis reactions. Fürstner and colleagues have shown that α,ω57

diene or ene-yne systems can undergo ring closing metathesis, catalyzed by the Grubbs
catalyst, to provide pyrrolidine-derived α,ω-dienes such as pyrrolidinoazepinone. (65)
Now that a brief review of the current methods employed to synthesize pyrrolidine,
pyrrolines, and azepines has been discussed, the pharmaceutical application of these
featured organic structures will be reviewed.
2.2 Pharmaceutical Relevance
Pyrrolidines, pyrrolines, and azepines are a crucially important families of
nitrogen containing heterocyclic, organic compounds which are shown to have varied
biological activities. When pyrrolidines, pyrrolines, or azepines are further
functionalized, or substituted, the resulting complex heterocyclic derivatives have shown
a wide variety of different antibacterial effects and significant biological activities.
Complex pyrrolidine moieties, for example, are used as scaffolding molecules to
synthesize unnatural oligomers. These synthetically made polymers, also known as
unnatural oligomers, show many diverse applications in the pharmaceutical industry as
antidiabetic, anticancer, antimalarial, antiviral, antimicrobial, anti-inflammatory, and
antibacterial agents. The following section will illustrate a few pharmaceutical
applications which employ pyrrolidines, pyrrolines, and azepines.
One of the first pharmaceutical applications that can be considered for nitrogencontaining heterocyclic compound can be seen through the presence of these structures
within natural products that are used in daily life as well as in synthetic organic
chemistry. Natural alkaloids including nicotine, hygrine, atropinone, and proline are just
a few examples of widely used natural products that have the pyrrolidine ring
substructure within each of the natural product’s molecular skeleton. (61) For
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applications within synthetic organic research, the pyrrolidine substructure acts as a great
nucleophile which can easily perform electrophilic substitution reaction with different
electrophiles including alkyl halides and acyl halides to provide substituted pyrrolidine
derivatives. Once these pyrrolines are formed, they can undergo even further
transformations such as N-alkylpyrrolidines which can produce quaternary salts on
further reaction with alkyl halides. Pyrrolidines have also been shown to react with
ketene thioacetals to synthesize mono- and di-pyrrolidino derivatives. One final example
of the synthetic application of pyrrolidines can be seen between the reaction of
pyrrolidines with alkyl/aryl isocyanates or isothiocyanates deliver the respective 1,3disubstituted urea/thiourea products. (61)
Gataullin and co-workers have synthesized N-tosyl-2-(1-halogeneethyl)-3methylindolines through halocyclization of homologues of N-tosyl2-(1-methylbut-2-en1-yl)aniline and 2-chloro-, 2-bromo-, and 4-bromo-derivatives. N-tosyl-2-(1halogeneethyl)-3-methylindolines synthesized by Gataullin and co-workers have shown
selective toxicity against SH-SY5Y cell lines which are often used as in vitro models of
neuronal function and differentiation. The synthesis of these N-tosyl-2-(1-halogeneethyl)3-methylindolines begins with the N-alkenylation of halogenated anilines which
chloropentene in triethylamine at 80 degrees Celsius. A thermal Claisen rearrangement
was then conducted on the hydrochloride penteneyl aniline in the presence of xylene. The
aniline derivatives produced then undergo reaction with tosyl chloride in pyridine to
afford cis and trans toluene sulfonyl amide derivatives which then undergo heterocyclization reaction in the presence of molecular iodine and sodium bicarbonate in
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dichloromethane at 20 degrees Celsius. The corresponding cis and trans isomers of Ntosyl-2-(1-halogeneethyl)-3-methylindolines are then produced. (82)
Pyrrolines have also been shown to have useful biological applications within the
pharmaceuticals industry. Pyrroline-5-carboxylate synthase (P5CS), for example, is a
bifunctional enzyme that exhibits glutamate kinase (GK) and gamma-glutamyl phosphate
reductase (GPR) activities. This P5CS enzyme is highly relevant in humans as it belongs
to a combined biochemical route for the conversion of glutamate, ornithine and proline.
Humans that have a P5CS deficiency exhibit a rare, metabolic disease that can be life
threatening if not addressed. It is well established that some bacteria and plants also
accumulate prolines in response to osmotic stress. The analyzed structures of GK and
GPR exemplify the importance of prolines in P5CS’s as they are present in a variety of
different species. (68)
Another biologically crucial proline derivative can be seen in D-Pyrroline-5carboxylic acid, an intermediate in both the biosynthesis and degradation of L-proline. Dpyrroline-5-carboxylic acid was recently synthesized and isolated as a pure compound
through enzymatic assay with pyrroline-5-carboxylate reductase from Escherichia coli by
the periodate oxidation of hydroxylysine. (69)
As chiral, pyrroline moiety-containing, tetrahydroindoles are represented in
natural products such as strychnine and mesembrine, a synthesis of chiral
tetrahydroindoles has been developed via a Pd-catalyzed asymmetric allylic substitution
annulation using unstable enolizable ketimines as nucleophiles and t-BuRuPHOX as a
chiral ligand. This reaction is depicted in Figure 14 below. The tetrahydroindole synthesis
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proceeds via an asymmetric desymmetrization of the mesodiacetate cycloalkenes,
generating the desired chiral tetrahydroindoles in excellent, 96% ee, yields. The
annulation reaction could be performed on a gram-scale in high yields and the resulting
products can be transformed to several types of N-hetereo bicyclic derivatives. (83)

Figure 14
Palladium Catalyzed Synthesis of Tetrahydroindoles

Azepines have also shown to be malleable organic constructs that can undergo
useful transformations to generate complex scaffolds that are likely characterized with
biological activities. As shown in Figure 15, if the nitrogen atom of 1H-azepines contains
an electron withdrawing group, of 2-azabicyclo [3.2.0] hepta-3,6-dienes can be produced
under photochemical conditions. Interestingly, the reverse reaction can occur by
producing 1H-azepines from of 2-azabicyclo [3.2.0] hepta-3,6-dienes through thermal
ring opening. (66)
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Figure 15
Functionalization of EWG Substituted 1H-Azepines

Azepines can also undergo alkylation reactions as tricarbonyl [4-1(ethoxycarbonyl)-1H-azepine] iron complex alkylation occurs through a Friedel-Craft
approach by using a 2-oxallyl cation. This cation is first generated by the reaction of 2,4dibromo-2,4-dimethylpentan-3-one and Fe(CO)9. (67)
Finally, azepines can be seen in innate natural products such as flueggenine C,
fluevirosine D, and phyllantidine which are depicted in Figure 16. Lee and colleagues
studied various synthetic routes that are currently available to afford these structures. In
the first mode of diversification to produce flueggenine C, as well as fluevirosine D, a
Rauhut-Currier reaction is undertaken each respective natural product precursor which
involves the formation of a carbon-carbon bond. (84) The other notable mode of
diversification that was used in the organic precursors by Lee and colleagues to afford
these azepine natural product derivatives was through oxidation procedures. The
oxidation of the tertiary amine moiety of securinega precursors yielded nitrogen-oxide
derivatives which could serve as a branching point for various high-oxidation state
securinega alkaloids. An example of the production of a high-oxidation state securinega
alkaloid natural products from nitrogen-oxide derivatives could use the Meisenheimer
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rearrangement on these produced nitrogen-oxide derivatives to yield the natural product
phyllantidine, also depicted in Figure 16. (85)

Figure 16
Azepine-Containing Natural Products

2.3 Results and Discussion
As depicted in the previous sections of this chapter, pyrrolidines, pyrrolines, and
azepines are crucial nitrogen-containing, heterocyclic organic structures that show up
extensively within valuable natural products, in the molecular skeleton of
pharmacophores, and as intermediates for the synthesis of complex pharmacophores.
Because of the scarcely of novel synthetic methods to afford pyrrolidines and azepines
the GML lab group developed a reaction hypothesis, depicted in Table 7, to provide these
nitrogen containing heterocycles from haloaziridines. Halogen bonding was an important
aspect to the products formed by the GML lab group as it added a layer of diversification
to the nitrogen containing heterocycles synthesized. Halogen bonding is exemplified as
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covalent bonding formed between a halogen atom, such as bromine or iodine, and a
nucleophile such as a Lewis base. Halogen bonding that exists within organic products
are highly directional and specific organic interactions that emulate the reactivity of
hydrogen bonding. (78) Due to the anisotropy of the charge distribution of halogen
atoms, a positively charged electrostatic region on the extension of the halogen bond,
termed the σ-hole, interacts attractively with a nucleophile to make the attached halogen
atom a good leaving group. (79) Over the past few years halogen bonding has more
attention for its role in drug discovery which has led the GML lab group to include them
in their novel synthetic methods. The haloaziridines produced in the reaction hypothesis,
in Table 7, are formed by transformation of halogenated allylic alkene derivatives
through reaction with chloramine T in the organic solvent acetonitrile at room
temperature. From this point, the haloaziridine derivatives produced are to undergo
cycloaddition with various catalytic methods to afford the pyrrolidine, pyrroline, and
azepine structures.
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Table 7
Selective Synthesis of Pyrrolidines, Pyrrolines, and Azepines From Haloaziridines
Reaction Hypothesis

Once the reaction hypothesis was formed, optimization studies for the synthesis of
haloaziridines was started by trying to maximize the haloaziridine yields. At the
beginning of the optimization studies, haloaziridine conversion was lacking so the GML
lab group employed the addition of iodine sublimed as a co-additive in order to convert
major side product of the halo-aziridination reaction, N-allyl-4methylbenzenesulfonamide into the aforementioned haloaziridine product. A solvent
study was also conducted on the reaction including the use of dichloromethane,
acetonitrile, chloroform, and benzene. As acetonitrile proved to show the best conversion
by NMR analysis, an organic solvent concentration study was performed which resulted
in the 0.05 M concentration of the acetonitrile. The scope of the haloaziridines produced
by the GML lab group can be seen in Table 9.
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Table 8
Synthesis of Haloaziridines Optimization Studies
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Table 9
Synthesis of Haloaziridines Reaction Scope
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2.3.1 Haloaziridine Cycloaddition Initial Studies
Initial studies were conducted on the transformation of the allylic bromide
haloaziridine derivative into the pyrrolidine, pyrroline, and azepine moieties. Boron
trifluoride ethyl etherate, silver hexafluoroantimonate(V), and chloro (1,5cyclooctadiene) rhodium(I)dimer were reacted with the haloaziridine derivative in
dichloroethane at 80 degrees Celsius to afford the pyrrolidine, pyrroline, and azepine
moieties, respectively. The presence of these heterocyclic constructs were confirmed by
NMR analysis in the crude products but further optimization is still required to maximize
the nitrogen containing heterocyclic products.

Table 10
Initial Cycloaddition Studies of Haloaziridines Into Pyrrolidines, Pyrrolines, and
Azepines
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2.4 Conclusion
A diastereoselective and efficient methodology was developed for the selective
synthesis of complex haloaziridines from allylic alkene derivatives. This overall reaction
will allow for the direct conversion of commercially available alkenyl halides in the
corresponding haloaziridines in the presence of chloramine T as the nitrogen source and
iodine sublimed to convert the main predicted organic side product into haloaziridines.
Initial studies on the conversion of these afforded haloaziridines into pyrrolidines,
pyrrolines, and azepines has been conducted and further optimization is needed. Initial
studies have proven that haloaziridines can be used as suitable templated for the synthesis
of nitrogen-containing heterocycles with high product conversion and stereoselectivity.
2.5 Experimental
Organic reagents were obtained from Aldrich Chemical, Acros Organics, and Alfa
Aesar. Organic reactions were performed with 20 milliliter glass vials that allowed for
magnetic stirring. TLC analysis was performed via a 0.25mm E. Merck silica gel 60 F254
plates and visualized under 254 nm UV light as well as staining with potassium
permanganate solution (KMnO4). Products were purified via manual silica-gel flash
chromatography and collected based on NMR analysis and Rf values of UV spots by
TLC. NMR spectrum were recorded via Varian Mercury II 400 MHz Spectrometer at 24
degrees Celsius in CDCl. Chemical shifts are expressed in ppm relative to solvent
signals: CDCl, (1 H, 7.23 ppm; 13C, 77.0ppm; coupling constants expressed in Hz)
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2.5.1 General Method for the Synthesis of Haloaziridines
A twenty-milliliter vial was obtained for this reaction and was filled with 0.1 M of
the organic solvent acetonitrile. Alkenes that had functional groups in the allylic position
were of interest for this project’s transformation. 0.4132 mmol of dry chloramine T was
put into a separate vial and put under high vacuum pressure for thirty minutes in order to
ensure it was completely dry. 0.2066 mmol of allyl bromide was syringed into the
reaction vial containing the 0.1M acetonitrile as well as a magnetic stir bar. The dry
chloramine T was then poured into the vial. The reaction was left to spin on a hotplate for
fifteen minutes at which point 0.2066 mmol of iodine sublimed was added to the reaction
vial. The reaction was then left to run overnight.
The following day the workup, characterization, and analysis of the halo-aziridine
formation took place. The aziridine reaction was taken off the hotplate, the stir bar was
removed with a magnetic stir rod, and the stir bar was cleaned. A clean 250 milliliter
Erlenmeyer flask was obtained along with a plastic funnel and a circular piece of filter
paper. The filter paper was folded and placed into the funnel and the funnel was then
placed into the 250 milliliter Erlenmeyer flask. A glass pipette was obtained with an
attached rubber bulb and used to squirt acetonitrile on the filter paper before the gravity
filtration of the reaction began. Gravity filtration was complete to remove the chloramine
T. Once the crude product was confirmed by TLC and NMR, manual, silica-based, flash
column chromatography was performed to isolate the pure haloaziridine product. The
pure haloaziridine was characterized/confirmed via proton/carbon NMR, infrared
spectroscopy (IR), and mass spectrometry (MS).
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2.5.2 Synthesis of Pyrrolidines, Pyrrolines, and Azepines From Table 9

JDH-154-2c

2-[bromo(phenyl)methyl]-1-(4-methylbenzene-1-sulfonyl)aziridine (2c): Purification
via manual silica gel flash chromatography (100:1 heptanes/EtOAc to 20:1
heptanes/EtOAc) afforded the haloaziridine product 2c as a clear oil. 1H NMR: δ 2.32
(3H, s), 3.13 (1H, dd, J = 8.1, 4.1 Hz), 3.29-3.47 (2H, 3.36 (dd, J = 7.6, 4.1 Hz), 3.39
(ddd, J = 8.1, 7.6, 6.5 Hz)), 4.85 (1H, d, J = 6.5 Hz), 7.23-7.53 (7H, 7.30 (tt, J = 7.7, 1.5
Hz), 7.33 (dddd, J = 7.9, 1.5, 1.3, 0.5 Hz), 7.34 (ddd, J = 7.9, 1.8, 0.4 Hz), 7.46
(dddd, J = 7.9, 7.7, 1.7, 0.5 Hz)), 7.70 (2H, ddd, J = 7.9, 1.5, 0.4 Hz).

JDH-165-2e

2-(2-bromo-6-methylhept-5-en-2-yl)-1-(4-methylbenzene-1-sulfonyl)aziridine (2e):
Purification via manual silica gel flash chromatography (100:1 heptanes/EtOAc to 20:1
heptanes/EtOAc) afforded the haloaziridine product 2e as a clear oil. 1H NMR: δ 1.19
(3H, s), 1.46-1.59 (8H, 1.52 (t, J = 7.4 Hz), 1.52 (t, J = 7.4 Hz), 1.54 (s), 1.54 (s)), 1.972.10 (2H, 2.04 (td, J = 7.4, 7.1 Hz), 2.04 (td, J = 7.4, 7.1 Hz)), 2.32 (3H, s), 3.07-3.23
(2H, 3.13 (dd, J = 8.1, 4.1 Hz), 3.16 (dd, J = 8.1, 7.6 Hz)), 3.39 (1H, dd, J = 7.6, 4.1 Hz),
5.27 (1H, t, J = 7.1 Hz), 7.34 (2H, ddd, J = 7.9, 1.8, 0.4 Hz), 7.70 (2H, ddd, J = 7.9, 1.5,
0.4 Hz).

JDH-181-2g

2-(Iodomethyl)-1-(4-methylbenzene-1-sulfonyl)aziridine (2g): Purification via manual
silica gel flash chromatography (100:1 heptanes/EtOAc to 20:1 heptanes/EtOAc)
afforded the haloaziridine product 2g as a clear oil. 1H NMR: δ 2.32 (3H, s), 3.13 (1H,
dd, J = 8.1, 4.1 Hz), 3.30-3.59 (4H, 3.37 (dd, J = 7.6, 4.1 Hz), 3.48 (d, J = 3.2 Hz), 3.48
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(d, J = 3.2 Hz), 3.52 (ddt, J = 8.1, 7.6, 3.2 Hz)), 7.32 (2H, ddd, J = 7.9, 1.8, 0.4 Hz), 7.70
(2H, ddd, J = 7.9, 1.5, 0.4 Hz).

JDH-189-2a

2-(bromomethyl)-1-(4-methylbenzene-1-sulfonyl)aziridine (2a): Purification via
manual silica gel flash chromatography (100:1 heptanes/EtOAc to 20:1 heptanes/EtOAc)
afforded the haloaziridine product 2a as a clear oil. 1H NMR: δ 2.32 (3H, s), 3.13 (1H,
dd, J = 8.1, 4.1 Hz), 3.33 (1H, dd, J = 7.6, 4.1 Hz), 3.49 (1H, ddt, J = 8.1, 7.6, 3.2 Hz),
3.98-4.09 (2H, 4.04 (d, J = 3.2 Hz), 4.04 (d, J = 3.2 Hz)), 7.34 (2H, ddd, J = 7.9, 1.8, 0.4
Hz), 7.70 (2H, ddd, J = 7.9, 1.5, 0.4 Hz).

JDH-184-2f

2-(1-bromoethyl)-1-(4-methylbenzene-1-sulfonyl)aziridine (2f): Purification via
manual silica gel flash chromatography (100:1 heptanes/EtOAc to 20:1 heptanes/EtOAc)
afforded the haloaziridine product 2f as a clear oil. 1H NMR: δ 1.45 (3H, d, J = 6.7 Hz),
2.32 (3H, s), 3.07-3.40 (3H, 3.13 (dd, J = 8.1, 4.1 Hz), 3.23 (ddd, J = 8.1, 7.6, 4.3 Hz),
3.34 (dd, J = 7.6, 4.1 Hz)), 4.21 (1H, qd, J = 6.7, 4.3 Hz), 7.32 (2H, ddd, J = 7.9, 1.8, 0.4
Hz), 7.70 (2H, ddd, J = 7.9, 1.5, 0.4 Hz).

JDH-185-2h

2-(chloromethyl)-1-(4-methylbenzene-1-sulfonyl)aziridine (2h): Purification via
manual silica gel flash chromatography (100:1 heptanes/EtOAc to 20:1 heptanes/EtOAc)
afforded the haloaziridine product 2h as a clear oil. 1H NMR: δ 1.36 (3H, d, J = 5.4 Hz),
2.32 (3H, s), 3.37-3.53 (2H, 3.44 (dq, J = 8.1, 5.4 Hz), 3.47 (dt, J = 8.1, 3.3 Hz)), 4.114.22 (2H, 4.16 (d, J = 3.3 Hz), 4.16 (d, J = 3.3 Hz)), 7.32 (2H, ddd, J = 7.9, 1.8, 0.4 Hz),
7.70 (2H, ddd, J = 7.9, 1.5, 0.4 Hz).
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JDH-186-2d

2-(1,2-dibromoethyl)-1-(4-methylbenzene-1-sulfonyl)aziridine (2d): Purification via
manual silica gel flash chromatography (100:1 heptanes/EtOAc to 20:1 heptanes/EtOAc)
afforded the haloaziridine product 2d as a clear oil. 1H NMR: δ 2.32 (3H, s), 3.09-3.46
(3H, 3.16 (dd, J = 8.1, 4.1 Hz), 3.28 (ddd, J = 8.1, 7.6, 3.2 Hz), 3.39 (dd, J = 7.6, 4.1
Hz)), 3.50-3.61 (2H, 3.56 (d, J = 5.4 Hz), 3.56 (d, J = 5.4 Hz)), 4.32 (1H, td, J = 5.4, 3.2
Hz), 7.32 (2H, ddd, J = 7.9, 1.8, 0.4 Hz), 7.70 (2H, ddd, J = 7.9, 1.5, 0.4 Hz).
2.5.3 Synthesis of Pyrrolidines, Pyrrolines, and Azepines – 1H NMR Spectra
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Chapter 3

Photo-Induced Isomerization of Vinyl Nitrones to Vinyl Oxaziridines

Oxaziridines are classically valuable moieties that become the targets for many
organic chemists looking to improve on the organic methodologies involved with making
complex pharmacophores as well as natural products. Research involving oxaziridines
over the past five decades has been motivated by the unusual physical properties
possessed by these compounds as well as their distinctive reactivity. Oxaziridines can be
characterized in Figure 17 by a three membered organic ring containing one carbon atom,
one nitrogen, and one oxygen atom. The presence of these two electronegative atoms
allow for further functionalization of oxaziridines into more complex heterocycles as,
under varying reaction conditions, the carbon-nitrogen bond, carbon-oxygen bond, and
oxygen-nitrogen bond can all be cleaved in order to afford a slew of heterocycles with an
added level of functionalization. The following section will introduce oxaziridines by
reviewing a few synthetic organic methods developed in order to synthesize oxaziridines.

Figure 17
Oxaziridine Moiety
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3.1 Synthesis of Oxaziridines
Oxaziridines have shown to be crucial organic scaffolds as well as acting as
reagents for the synthesis of even more complex heterocyclic containing complexes. One
of the most well characterized reactivities that oxaziridines can provide to organic
chemists is their ability to serve as electrophilic oxygen transfer reagents. Numerous,
thorough reviews have been published with a focus on oxaziridines used as electrophilic
oxygen transfer reagents. (70) There has been recent significant growth of synthetic
routes that have become available in oxaziridine chemistry allowing for the synthesis of
highly functionalized, stereospecific oxaziridine moieties. The following brief review, in
this section, of the current methods to provide oxaziridines will be organized via the
substituent of the nitrogen atom in the oxaziridine moiety.
The first class of N-substituted oxaziridines explored by organic chemists were Nalkyl-substituted oxaziridines, initially synthesized by Emmons and coworkers in 1957.
The standard method for Emmon’s preparation of the N-alkyl-substituted oxaziridines
involves the oxidation of an imine to then afford the corresponding oxaziridine. The use
of peroxy-acids, described in Emmons initial report and depicted in Figure 18, such as mchloroperbenzoic acid (mCPBA) to oxidize imines continues to be the most common
method utilized by organic chemists today for oxaziridine synthesis. Experimental and
theoretical studies of Emmon’s oxaziridines synthesis support a two-step mechanism for
imine oxidation. (71)
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Figure 18
Emmons Synthesis of N-Alkyl Substituted Oxaziridines

The next class of oxaziridines which will be discussed are N-unsubstituted
oxaziridines. N-Unsubstituted oxaziridines are useful organic moieties as they are highly
reactive toward nucleophiles and are usually formed in situ in inert solvents and reacted
further without the need for additional purification procedures. (70) Oxaziridines bearing
unsubstituted nitrogen atoms are generally not synthesized by standard peracid oxidation
methods due to the instability of N-H imines. Schmitz et al. have reported the preparation
of N- unsubstituted oxaziridines through the reaction of cyclohexanone with ammonia
and sodium hypochlorite. (72)
Another notable type of N-substituted oxaziridines, to which previously
developed methods exist, are N-sulfonyloxaziridines. N-sulfonyloxaziridines are highly
selective, neutral, aprotic oxidizing reagents that have found, and are continuing to find,
increased utility in organic synthesis. Enantiomerically pure examples of Nsulfonyloxaziridines are useful asymmetric oxidizing reagents to afford high
stereoselectivities for the asymmetric oxidation of sulfides (selenides) to sulfoxides
(selenoxides) (66 to >95% ee), for the epoxidation of alkenes (up to 65% ee), and for the
asymmetric oxidation of enolates to optically active hydroxycarbonyl compounds (5580

95% ee). (73) The earliest attempts to prepare optically active N-sulfonyloxaziridines
relied on catalysis from chiral camphor-based peracids. (74) This was not viable for
continued use as the approach suffers from low selectivity and repeated fractional
recrystallizations are required to achieve high optical purity using this protocol. The first
synthetically useful approach to chiral N-sulfonyloxaziridines was based on the synthesis
of camphor sulfonic acid derived imines which can be selectively oxidized with oxone to
give the corresponding chiral N-sulfonyloxaziridines. This oxidation can only take place
from the endo face of the carbon and nitrogen double bond due to the steric blocking of
the exo-face, resulting in a single oxaziridine isomer (75) Because of the multitude of
uses discovered with N-sulfonyloxaziridines chemistry, N-sulfonyloxaziridines have
quickly become the most extensively utilized class of oxaziridines in organic synthesis
research due of their stability, ease of synthesis, and superior oxidizing ability compared
to N-alkyloxaziridines. Now commonly referred to as “Davis’ oxaziridines”, Nsulfonyloxaziridines are prepared through oxidation of the corresponding N-sulfonyl
imines, which in turn can be prepared by condensation of sulfonamides (R-SO2NH2) with
aromatic aldehydes using either Bronsted or Lewis acids. (70)
The final N-substituted oxaziridines that will be discussed in this chapter are Nphosphinoyl substituted oxaziridines. Oxaziridines bearing the N-phosphinoyl
substitution groups were first synthesized by Boyd et al. (76) This featured class of
substituted oxaziridines are typically accessed via a reaction of an aryl oximes with
chlorodiphenylphosphine, followed by oxidation of the corresponding, rearranged Nphosphinoyl imines with mCPBA. The oxaziridines produced from this method are
characterized as stable compounds that have a low barrier to nitrogen inversion (∼13
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kcal/mol) and exist in the trans-configuration. This barrier of inversion is lower than for
the related N-sulfonyloxaziridines due to the effect of a stronger conjugative interaction
between nitrogen and phosphorus atoms in N-phosphinoyl oxaziridines than the
interaction between nitrogen and sulfur atoms in N-sulfonyloxaziridines in the transition
state for epimerization. (77) Now that current methods for the synthesis of oxaziridines
have been discussed, pharmaceutical and synthetic applications of oxaziridines will be
reviewed.
3.2 Pharmaceutical Relevance
Oxaziridines have been proven time and time again to be useful reagents in both
organic synthesis as well as in the production of molecularly complex pharmacophores.
In each case, the stereochemistry and conformation of the afforded oxaziridines used, and
its substituents, are critical to exploring what types of further transformations they can
then undergo. N-Alkyl oxaziridines are useful intermediates, for example, for the
synthesis of amides and lactams and have been used more recently to prepare chiral
pyrrolidines and aziridines via nitrogen-centered radicals. The potential of oxaziridines as
enzyme inhibitors has also been recognized from the findings of the previously
mentioned application of N-alkyl oxaziridines. (80)
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Figure 19
Synthesis of Fused Bicyclic Lactams From Oxaziridine Derivatives

Another example of the application of oxaziridines, depicted in Figure 19, is
through the synthesis of fused bicyclic lactams as non-peptide scaffolds mimicking
peptidyl alpha-turn topology. The final product of this synthesis, the 1-azabicyclo [5.2.0]
nonan-2-one bicyclic skeleton, has very few existing synthesis methods but the available
routes are not straightforward and usually result in low product yields. The synthesis of
1-azabicyclo [5.2.0] nonan-2-one lactam, containing a bridgehead nitrogen atom, is
offered in Figure 19 by the photolysis of a cyclic oxaziridine derivative or the
corresponding nitrone shown on the right of Figure 19. The photolysis of the cyclic
nitrone leads to an oxaziridine intermediate before completing the transformation in the
corresponding lactam. (86)
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Figure 20
Lewis Acid Promoted [3+2] Cycloaddition of Oxaziridines & Allylic Alcohols

Figure 20 illustrates another application of oxaziridines through the synthesis of
novel bicyclic isoxazolidine-containing compounds through 1,3-dipolar cycloaddition
reactions between cyclic allylic alcohols and oxaziridines as substrates. The power of this
synthetic route is that the current methods for the synthesis of isoxazolidines, through the
carbonyl imine intermediates, are currently limited to monosubstituted olefin substrates.
This reaction shows high product conversion and the reaction substrates tolerate various
functional groups including the cyclopropyl and amine substituents. Mechanistic studies
suggest the stereochemistry and diasteroeselectivity of the produced isoxazolidines are
due to the allylic cation and a carbonyl imine intermediate. (87)
The final example of the application of oxaziridines, discussed in this section, is a
collection of cycloaddition reactions involving the cleavage of the N−O bond of an
oxaziridine as this type of reaction mechanism has received increased attention in the past
few years. The value of this synthetic route comes from the fact that direct, uncatalyzed
oxyamination reactions between oxaziridines and olefinic substrates are quite hard to
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achieve. Desmarteau and colleagues however have reported that electron-deficient 1,1difluoroalkenes reacted with perfluoro-oxaziridine affords 1,3-oxazolidine in excellent
yields. One caveat to Desmarteau’s reaction is that only electron deficient alkenes
undergo this atypical amino-hydroxylation transformation. (88) While only a few of the
many examples of the applications of oxaziridines have been discussed in this section, it
is clear to see why the GML lab group have chosen these valuable moieties as target
structures for selective synthesis within mild conditions.
3.3 Results and Discussion
As mentioned before, oxaziridines continue to become an ever-present molecular
target for synthetic chemists as they are common intermediates for the synthesis of
biologically active, complex scaffolds used in the creation of new pharmacophores. The
work I completed in the GML lab group finished the reaction scope of the novel synthetic
pathway for the photocatalytic synthesis of vinyl oxaziridines from vinyl nitrones. Vinyl
oxaziridines are seen as more valuable targets than oxaziridines alone as they add two
points of diversification to the oxaziridines structure allowing for even greater
opportunities for further functionalization of the molecule. This pathway was initially
achieved by first looking at the methods previously developed to synthesize the
oxaziridine moiety. As seen in a few synthetic examples discussed in previous sections,
imine oxidation is a preferred pathway to afford oxaziridines as imines provide superior
heteroatom transfer agents in oxaziridine synthesis. The GML lab group had previously
synthesized a library of vinyl nitrones which were now available for photoisomerization
to form their respective vinyl oxaziridines. Photoisomerization of vinyl nitrones to vinyl
oxaziridines was an attractive organic method to explore as it provides mild reaction
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conditions to afford the valuable oxaziridine moiety. This photocatalytic reaction
pathway was first realized by leaving the vinyl nitrones in solution on a windowsill for 18
hours, in the visible light from the sun, showing the lowest conversion. This method was
then further developed to use LED light bulbs as the visible light source instead of
sunlight as sunlight is not nearly as direct as white LED light bulbs and the vinyl nitrones
in solution were not being excited to a state where isomerization occurs. Tcinnamaldehydes derived nitrones were used along with white LED light in a lightbox,
with and without catalyst, during the optimization studies which produced oxaziridines in
excellent yields. (81) The optimization studies for this reaction can be seen in Table 12.
The reaction hypothesis for this photoisomerization transformation can be seen in Table
11. These results were surprising as previous reports of nitrone isomerization required
UV irradiation in order to promote a similar transformation. (89) The reaction scopes for
the photoisomerization transformation can be seen in Table 14 and Table 15.

Table 11
Photo-Induced Isomerization of Vinyl Nitrones to Vinyl Oxaziridines Reaction
Hypothesis
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Table 12
Synthesis of Vinyl Oxaziridines Optimization Studies

Table 13
Synthesis of Vinyl Oxaziridines Hypothesized Visible-Light Photosensitized Mechanism
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Table 14
Synthesis of Vinyl Oxaziridines Reaction Scope 1
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Table 15
Synthesis of Vinyl Oxaziridines Reaction Scope 2
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3.4 Experimental
Organic reagents were obtained from Aldrich Chemical, Acros Organics, and Alfa
Aesar. Organic reactions were performed with 20 milliliter glass vials that allowed for
magnetic stirring. TLC analysis was performed via a 0.25mm E. Merck silica gel 60 F254
plates and visualized under 254 nm UV light as well as staining with potassium
permanganate solution (KMnO4). Products were purified via manual silica-gel flash
chromatography and collected based on NMR analysis and Rf values of UV spots by
TLC. NMR spectrum were recorded via Varian Mercury II 400 MHz Spectrometer at 24
degrees Celsius in CDCl. Chemical shifts are expressed in ppm relative to solvent
signals: CDCl, (1 H, 7.23 ppm; 13C, 77.0ppm; coupling constants expressed in Hz)
3.4.1 General Method for Synthesis of Vinyl Nitrones
A reaction vial was obtained and 0.1M of the organic solvent acetonitrile (ACN)
was pipetted into the vial. Next, 1.296 mmol of magnesium sulfate was weighed out and
placed into the 20-milliliter reaction vial. 1.944 mmol of N-benzyl hydroxylamine was
measured and added to the reaction vial followed by the final reagent which was 1.296
mmol of a vinyl ketone or vinyl aldehyde. The reaction was run overnight at room
temperature.
The workup of the crude product was started the following day. The workup of
the vinyl nitrone created from the first step involved gravity filtration to remove the
excess magnesium sulfate in the reaction which was then run in the rotatory evaporator to
remove the acetonitrile in the reaction. 10 milliliters of DI water were added to the
reaction vial and liquid/liquid extraction was performed with the water and three washes
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of ethyl acetate. The ethyl acetate layer was collected, and sodium sulfate was added to
remove any of the remaining water with the reaction. The reaction was then gravity
filtered to remove the magnesium sulfate previously added. The reaction was rotatory
evaporated and the crude product was confirmed by TLC and NMR. It was at this point
that if the crude was an oil, manual, silica-based, flash column chromatography was
performed to isolate the pure vinyl nitrone product. If the crude product at the end of the
work up was a solid, then a pentane decanting was performed in order to isolate the vinyl
nitrone shown on the left of Figure 6. The pure vinyl nitrone was characterized/confirmed
via proton/carbon NMR, infrared spectroscopy (IR), and mass spectrometry (MS).
3.4.2 General Method for Synthesis of Vinyl Oxaziridines
The final step of the synthesis of vinyl oxaziridines involved taking a new 20milliliter reaction vial and filling it with 0.1M of the organic solvent acetonitrile. The
pure vinyl nitrone product was weight or measured out in a syringe and added to the 20milliliter reaction vial. 0.005M of the [Ru(bpy)3]2+ photocatalyst was added to the
reaction vial. One equivalence of molecular sieves was also added to the reaction vial to
keep the creation dry. The reaction vial was then placed into a lightbox with the lightbox
fan turned on for a total of 24 hours. The following day, the reaction was worked up
through gravity filtration to remove the molecular sieves followed by rotatory
evaporation of the crude reaction solution to remove organic solvent. The crude vinyl
oxaziridine reaction was purified via flash chromatography. The pure vinyl oxaziridine
was characterized/confirmed via proton/carbon NMR, infrared spectroscopy (IR), and
mass spectrometry (MS). The reaction schematic of the final step of the synthesis of vinyl
oxaziridine is shown below in Figure 6.
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